Log in | Register

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Andrew Rhodes| Laura E. Evans| Waleed Alhazzani| Mitchell M. Levy| Massimo Antonelli| Ricard Ferrer| Anand Kumar| Jonathan E. Sevransky| Charles L. Sprung| Mark E. Nunnally| Bram Rochwerg| Gordon D. Rubenfeld| Derek C. Angus| Djillali Annane| Richard J. Beale| Geoffrey J. Bellinghan| Gordon R. Bernard| Jean-Daniel Chiche| Craig Coopersmith| Daniel P. De Backer| Craig J. French| Seitaro Fujishima|
Conference Reports and Expert Panel
Volume 43, Issue 3 / March , 2017

Pages 304 - 377

Abstract

Objective

To provide an update to “Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012”.

Design

A consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for those committee members attending the conference). A formal conflict-of-interest (COI) policy was developed at the onset of the process and enforced throughout. A stand-alone meeting was held for all panel members in December 2015. Teleconferences and electronic-based discussion among subgroups and among the entire committee served as an integral part of the development.

Methods

The panel consisted of five sections: hemodynamics, infection, adjunctive therapies, metabolic, and ventilation. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. Each subgroup generated a list of questions, searched for best available evidence, and then followed the principles of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to assess the quality of evidence from high to very low, and to formulate recommendations as strong or weak, or best practice statement when applicable.

Results

The Surviving Sepsis Guideline panel provided 93 statements on early management and resuscitation of patients with sepsis or septic shock. Overall, 32 were strong recommendations, 39 were weak recommendations, and 18 were best-practice statements. No recommendation was provided for four questions.

Conclusions

Substantial agreement exists among a large cohort of international experts regarding many strong recommendations for the best care of patients with sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality.

Keywords

References

  1. Singer M, Deutschman CS, Seymour CW et al (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8):801–810
    • View reference on PubMed
    • View reference on publisher's website
  2. Shankar-Hari M, Phillips GS, Levy ML et al (2016) Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8):775–787
    • View reference on PubMed
    • View reference on publisher's website
  3. Seymour CW, Liu VX, Iwashyna TJ et al (2016) Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315(8):762–774
    • View reference on PubMed
    • View reference on publisher's website
  4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303–1310
    • View reference on PubMed
    • View reference on publisher's website
  5. Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31(3):946–955
    • View reference on PubMed
    • View reference on publisher's website
  6. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546–1554
    • View reference on PubMed
    • View reference on publisher's website
  7. Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4):1250–1256
    • View reference on PubMed
    • View reference on publisher's website
  8. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39(2):165–228
  9. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41(2):580–637
    • View reference on PubMed
    • View reference on publisher's website
  10. Dellinger RP, Carlet JM, Masur H et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32(3):858–873
    • View reference on PubMed
    • View reference on publisher's website
  11. Dellinger RP, Levy MM, Carlet JM (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36(1):296–327
    • View reference on PubMed
    • View reference on publisher's website
  12. Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36(1):296–327
    • View reference on PubMed
    • View reference on publisher's website
  13. Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64(4):395–400
    • View reference on PubMed
    • View reference on publisher's website
  14. Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924–926
    • View reference on PubMed
    • View reference on publisher's website
  15. Guyatt GH, Schunemann HJ, Djulbegovic B, Akl EA (2015) Guideline panels should not GRADE good practice statements. J Clin Epidemiol 68(5):597–600
    • View reference on PubMed
    • View reference on publisher's website
  16. Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377
    • View reference on PubMed
    • View reference on publisher's website
  17. Peake SL, Delaney A, Bailey M et al (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371(16):1496–1506
    • View reference on PubMed
    • View reference on publisher's website
  18. Yealy DM, Kellum JA, Huang DT et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370(18):1683–1693
    • View reference on PubMed
    • View reference on publisher's website
  19. Mouncey PR, Osborn TM, Power GS et al (2015) Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372(14):1301–1311
    • View reference on PubMed
    • View reference on publisher's website
  20. Levy MM, Dellinger RP, Townsend SR et al (2010) The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 38(2):367–374
    • View reference on PubMed
    • View reference on publisher's website
  21. Levy MM, Rhodes A, Phillips GS et al (2015) Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med 43(1):3–12
    • View reference on PubMed
    • View reference on publisher's website
  22. Cecconi M, De Backer D, Antonelli M et al (2014) Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 40(12):1795–1815
  23. Eskesen TG, Wetterslev M, Perner A (2016) Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness. Intensive Care Med 42(3):324–332
  24. Monnet X, Marik P, Teboul JL (2016) Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med 42(12):1935–1947
  25. Cecconi M, Hofer C, Teboul JL et al (2015) Fluid challenges in intensive care: the FENICE study: a global inception cohort study. Intensive Care Med 41(9):1529–1537
  26. LeDoux D, Astiz ME, Carpati CM, Rackow EC (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28(8):2729–2732
    • View reference on PubMed
    • View reference on publisher's website
  27. Bourgoin A, Leone M, Delmas A, Garnier F, Albanese J, Martin C (2005) Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 33(4):780–786
    • View reference on PubMed
    • View reference on publisher's website
  28. Thooft A, Favory R, Salgado DR et al (2011) Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care 15(5):R222
    • View reference on PubMed
    • View reference on publisher's website
  29. Asfar P, Meziani F, Hamel JF et al (2014) High versus low blood-pressure target in patients with septic shock. N Engl J Med 370(17):1583–1593
    • View reference on PubMed
    • View reference on publisher's website
  30. Lamontagne F, Meade MO, Hebert PC et al (2016) Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med 42(4):542–550
  31. Levy B (2006) Lactate and shock state: the metabolic view. Curr Opin Crit Care. 12(4):315–321
    • View reference on PubMed
    • View reference on publisher's website
  32. Casserly B, Phillips GS, Schorr C et al (2015) Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med 43(3):567–573
    • View reference on PubMed
    • View reference on publisher's website
  33. Jansen TC, van Bommel J, Schoonderbeek FJ et al (2010) Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 182(6):752–761
    • View reference on PubMed
    • View reference on publisher's website
  34. Jones AE, Shapiro NI, Trzeciak S et al (2010) Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303(8):739–746
    • View reference on PubMed
    • View reference on publisher's website
  35. Lyu X, Xu Q, Cai G, Yan J, Yan M (2015) Efficacies of fluid resuscitation as guided by lactate clearance rate and central venous oxygen saturation in patients with septic shock. Zhonghua Yi Xue Za Zhi. 95(7):496–500
    • View reference on PubMed
  36. Tian HH, Han SS, Lv CJ et al (2012) The effect of early goal lactate clearance rate on the outcome of septic shock patients with severe pneumonia. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 24(1):42–45
    • View reference on PubMed
  37. Yu B, Tian HY, Hu ZJ et al (2013) Comparison of the effect of fluid resuscitation as guided either by lactate clearance rate or by central venous oxygen saturation in patients with sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 25(10):578–583
    • View reference on PubMed
  38. Gu WJ, Zhang Z, Bakker J (2015) Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials. Intensive Care Med 41(10):1862–1863
  39. Simpson SQ, Gaines M, Hussein Y, Badgett RG (2016) Early goal-directed therapy for severe sepsis and septic shock: a living systematic review. J Crit Care 36:43–48
    • View reference on PubMed
    • View reference on publisher's website
  40. Dellinger RP (2015) Foreword. The future of sepsis performance improvement. Crit Care Med 43(9):1787–1789
    • View reference on PubMed
    • View reference on publisher's website
  41. Murphy DJ, Ogbu OC, Coopersmith CM (2015) ICU director data: using data to assess value, inform local change, and relate to the external world. Chest 147(4):1168–1178
    • View reference on PubMed
    • View reference on publisher's website
  42. Black MD, Schorr C, Levy MM (2012) Knowledge translation and the multifaceted intervention in the intensive care unit. Crit Care Med 40(4):1324–1328
    • View reference on PubMed
    • View reference on publisher's website
  43. Gatewood MO, Wemple M, Greco S, Kritek PA, Durvasula R (2015) A quality improvement project to improve early sepsis care in the emergency department. BMJ Qual Saf 24(12):787–795
    • View reference on PubMed
    • View reference on publisher's website
  44. Hayden GE, Tuuri RE, Scott R et al (2016) Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED. Am J Emerg Med 34(1):1–9
  45. Jones SL, Ashton CM, Kiehne L et al (2015) Reductions in sepsis mortality and costs after design and implementation of a nurse-based early recognition and response program. Jt Comm J Qual Patient Saf. 41(11):483–491
    • View reference on PubMed
    • View reference on publisher's website
  46. Levy MM, Pronovost PJ, Dellinger RP et al (2004) Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 32(11 Suppl):S595–S597
    • View reference on PubMed
    • View reference on publisher's website
  47. Damiani E, Donati A, Serafini G et al (2015) Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS One 10(5):e0125827
    • View reference on PubMed
    • View reference on publisher's website
  48. Rhodes A, Phillips G, Beale R et al (2015) The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med 41(9):1620–1628
  49. Zadroga R, Williams DN, Gottschall R et al (2013) Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy. Clin Infect Dis 56(6):790–797
    • View reference on PubMed
    • View reference on publisher's website
  50. Kanegaye JT, Soliemanzadeh P, Bradley JS (2001) Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 108(5):1169–1174
    • View reference on PubMed
  51. Pollack LA, van Santen KL, Weiner LM, Dudeck MA, Edwards JR, Srinivasan A (2016) Antibiotic stewardship programs in U.S. acute care hospitals: findings from the 2014 National Healthcare Safety Network Annual Hospital Survey. Clin Infect Dis. 63(4):443–449
  52. Cardoso T, Carneiro A, Ribeiro O, Teixeira-Pinto A, Costa-Pereira A (2010) Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study). Crit Care 14(3):R83
    • View reference on PubMed
    • View reference on publisher's website
  53. De Sousa AG, Fernandes Junior CJ, Santos GPD et al (2008) The impact of each action in the Surviving Sepsis Campaign measures on hospital mortality of patients with severe sepsis/septic shock. Einstein. 6(3):323–327
  54. Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A et al (2013) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 40(1):32-40. doi:10.1007/s00134-013-3077-7
  55. Weiss CH, Persell SD, Wunderink RG, Baker DW (2012) Empiric antibiotic, mechanical ventilation, and central venous catheter duration as potential factors mediating the effect of a checklist prompting intervention on mortality: an exploratory analysis. BMC Health Serv Res. 12(1):1
    • View reference on publisher's website
  56. Ferrer R, Artigas A, Suarez D et al (2009) Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 180(9):861–866
    • View reference on PubMed
    • View reference on publisher's website
  57. Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34(6):1589–1596
    • View reference on PubMed
    • View reference on publisher's website
  58. Vaughn VM, Chopra V (2016) Revisiting the panculture. BMJ Qual Saf. doi:10.1136/bmjqs-2015-004821(Epub ahead of print)
  59. Weinstein MP, Reller LB, Murphy JR, Lichtenstein KA (1983) The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 5(1):35–53
    • View reference on PubMed
    • View reference on publisher's website
  60. Li J, Plorde JJ, Carlson LG (1994) Effects of volume and periodicity on blood cultures. J Clin Microbiol 32(11):2829–2831
    • View reference on PubMed
  61. Baron EJ, Miller JM, Weinstein MP et al (2013) A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis 57(4):e22–e121
    • View reference on PubMed
    • View reference on publisher's website
  62. O’Grady NP, Alexander M, Burns LA et al (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52(9):e162–e193
    • View reference on PubMed
    • View reference on publisher's website
  63. Blot F, Schmidt E, Nitenberg G et al (1998) Earlier positivity of central venous versus peripheral blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 36(1):105–109
    • View reference on PubMed
  64. Kaasch AJ, Rieg S, Hellmich M, Kern WV, Seifert H (2014) Differential time to positivity is not predictive for central line-related Staphylococcus aureus bloodstream infection in routine clinical care. J Infect 68(1):58–61
    • View reference on PubMed
    • View reference on publisher's website
  65. Malgrange VB, Escande MC, Theobald S (2001) Validity of earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for diagnosing catheter-related bacteremia in cancer patients. J Clin Microbiol 39(1):274–278
    • View reference on PubMed
    • View reference on publisher's website
  66. O’Grady NP, Barie PS, Bartlett JG et al (2008) Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 36(4):1330–1349
    • View reference on PubMed
    • View reference on publisher's website
  67. Mermel LA, Allon M, Bouza E et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1–45
    • View reference on PubMed
    • View reference on publisher's website
  68. Boyce JM, Nadeau J, Dumigan D et al (2013) Obtaining blood cultures by venipuncture versus from central lines: impact on blood culture contamination rates and potential effect on central line-associated bloodstream infection reporting. Infect Control Hosp Epidemiol 34(10):1042–1047
    • View reference on PubMed
    • View reference on publisher's website
  69. Beekmann SE, Diekema DJ, Huskins WC et al (2012) Diagnosing and reporting of central line-associated bloodstream infections. Infect Control Hosp Epidemiol 33(9):875–882
    • View reference on PubMed
    • View reference on publisher's website
  70. Garcia RA, Spitzer ED, Beaudry J et al (2015) Multidisciplinary team review of best practices for collection and handling of blood cultures to determine effective interventions for increasing the yield of true-positive bacteremias, reducing contamination, and eliminating false-positive central line-associated bloodstream infections. Am J Infect Control 43(11):1222–1237
    • View reference on PubMed
    • View reference on publisher's website
  71. Vincent JL, Brealey D, Libert N et al (2015) Rapid diagnosis of infection in the critically ill, a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections. Crit Care Med 43(11):2283–2291
    • View reference on PubMed
    • View reference on publisher's website
  72. Makristathis A, Riss S, Hirschl AM (2014) A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures. Clin Microbiol Infect 20(10):O760–O763
    • View reference on PubMed
    • View reference on publisher's website
  73. Tissari P, Zumla A, Tarkka E et al (2010) Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 375(9710):224–230
    • View reference on PubMed
    • View reference on publisher's website
  74. Ferrer R, Martin-Loeches I, Phillips G et al (2014) Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42(8):1749–1755
    • View reference on PubMed
    • View reference on publisher's website
  75. Zhang D, Micek ST, Kollef MH (2015) Time to appropriate antibiotic therapy is an independent determinant of postinfection ICU and hospital lengths of stay in patients with sepsis. Crit Care Med 43(10):2133–2140
    • View reference on PubMed
    • View reference on publisher's website
  76. Bagshaw SM, Lapinsky S, Dial S et al (2009) Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35(5):871–881
  77. Iscimen R, Cartin-Ceba R, Yilmaz M et al (2008) Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med 36(5):1518–1522
    • View reference on PubMed
    • View reference on publisher's website
  78. Garnacho-Montero J, Aldabo-Pallas T, Garnacho-Montero C et al (2006) Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. Crit Care 10(4):R111
    • View reference on PubMed
    • View reference on publisher's website
  79. Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR (2005) Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect. 6(1):41–54
    • View reference on publisher's website
  80. Barochia AV, Cui X, Vitberg D et al (2010) Bundled care for septic shock: an analysis of clinical trials. Crit Care Med 38(2):668–678
    • View reference on PubMed
    • View reference on publisher's website
  81. Gaieski DF, Mikkelsen ME, Band RA et al (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38(4):1045–1053
    • View reference on PubMed
    • View reference on publisher's website
  82. Kumar A (2016) Systematic bias in meta-analyses of time to antimicrobial in sepsis studies. Crit Care Med 44(4):e234–e235
    • View reference on PubMed
  83. Shirakura Y, Kuriyama A (2016) Timing of antibiotic administration in sepsis and septic shock: the impact that a meta-analysis does not depict. Crit Care Med 44(10):e1004
    • View reference on PubMed
    • View reference on publisher's website
  84. Kaasch AJ, Rieg S, Kuetscher J et al (2013) Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study. Infection 41(5):979–985
    • View reference on PubMed
    • View reference on publisher's website
  85. Corona A, Bertolini G, Lipman J, Wilson AP, Singer M (2010) Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC). J Antimicrob Chemother 65(6):1276–1285
    • View reference on PubMed
    • View reference on publisher's website
  86. Giner AM, Kuster SP, Zbinden R, Ruef C, Ledergerber B, Weber R (2011) Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003-2009. Infection 39(6):519–526
    • View reference on PubMed
    • View reference on publisher's website
  87. Lin MY, Weinstein RA, Hota B (2008) Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob Agents Chemother 52(9):3188–3194
    • View reference on PubMed
    • View reference on publisher's website
  88. Amaral AC, Fowler RA, Pinto R et al (2016) Patient and organizational factors associated with delays in antimicrobial therapy for septic shock. Crit Care Med 44(12):2145–2153
    • View reference on PubMed
    • View reference on publisher's website
  89. Funk DJ, Kumar A (2011) Antimicrobial therapy for life-threatening infections: speed is life. Crit Care Clin 27(1):53–76
    • View reference on PubMed
    • View reference on publisher's website
  90. Petitpas F, Guenezan J, Vendeuvre T, Scepi M, Oriot D, Mimoz O (2016) Use of intra-osseous access in adults: a systematic review. Crit Care 20(1):102
    • View reference on PubMed
    • View reference on publisher's website
  91. Buck ML, Wiggins BS, Sesler JM (2007) Intraosseous drug administration in children and adults during cardiopulmonary resuscitation. Ann Pharmacother 41(10):1679–1686
    • View reference on PubMed
    • View reference on publisher's website
  92. Romanelli G, Cravarezza P, Group IIMS (1995) Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. J Antimicrob Chemother 36(suppl A):109–119
    • View reference on PubMed
    • View reference on publisher's website
  93. Cormio L, Berardi B, Callea A et al (2002) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU Int 90(7):700–702
    • View reference on PubMed
    • View reference on publisher's website
  94. Barbhaiya RH, Knupp CA, Tenney J, Martin RR, Weidler DJ, Pittman KA (1990) Safety, tolerance, and pharmacokinetics of cefepime administered intramuscularly to healthy subjects. J Clin Pharmacol 30(10):900–910
    • View reference on PubMed
    • View reference on publisher's website
  95. Kumar A, Ellis P, Arabi Y et al (2009) Initiation of inappropriate antimicrobial therapy results in a five-fold reduction of survival in human septic shock. Chest 136(5):1237–1248
    • View reference on PubMed
    • View reference on publisher's website
  96. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118(1):146–155
    • View reference on PubMed
    • View reference on publisher's website
  97. Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L (2010) Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54(11):4851–4863
    • View reference on PubMed
    • View reference on publisher's website
  98. Kreger BE, Craven DE, McCabe WR (1980) Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 68(3):344–355
    • View reference on PubMed
    • View reference on publisher's website
  99. Mermel LA, Maki DG (1993) Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 119(4):270–272
    • View reference on PubMed
    • View reference on publisher's website
  100. Bow EJ, Evans G, Fuller J et al (2010) Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol. 21(4):e122–e150
    • View reference on PubMed
  101. Connolly S (2011) Clinical Practice Guidelines: Burn Patient Management. ACI Statewide Burn Injury Service. Chatswood, NSW, Australia: NSW Agency for Clinical Innovation
  102. Cornely OA, Bassetti M, Calandra T et al (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7):19–37
    • View reference on PubMed
    • View reference on publisher's website
  103. Kalil AC, Metersky ML, Klompas M et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63(5):e61–e111
    • View reference on PubMed
    • View reference on publisher's website
  104. Liu C, Bayer A, Cosgrove SE et al (2011) Clinical Practice Guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52(3):e18–e55
    • View reference on PubMed
    • View reference on publisher's website
  105. Pappas PG, Kauffman CA, Andes DR et al (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):e1–e50
    • View reference on PubMed
    • View reference on publisher's website
  106. Penack O, Becker C, Buchheidt D et al (2014) Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Ann Hematol 93(7):1083–1095
    • View reference on PubMed
    • View reference on publisher's website
  107. Penack O, Buchheidt D, Christopeit M et al (2011) Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology. Ann Oncol 22(5):1019–1029
    • View reference on PubMed
    • View reference on publisher's website
  108. Solomkin JS, Mazuski JE, Bradley JS et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect. 11(1):79–109
    • View reference on publisher's website
  109. Stevens DL, Bisno AL, Chambers HF et al (2014) Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 59(2):147–159
    • View reference on PubMed
    • View reference on publisher's website
  110. Micek ST, Welch EC, Khan J et al (2010) Empiric combination antibiotic therapy is associated with improved outcome in gram-negative sepsis: a retrospective analysis. Antimicrob Agents Chemother (Bethesda). 54(5):1742–1748
    • View reference on publisher's website
  111. Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220(6):751–758
    • View reference on PubMed
    • View reference on publisher's website
  112. Blumberg HM, Jarvis WR, Soucie JM et al (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33(2):177–186
    • View reference on PubMed
    • View reference on publisher's website
  113. Green DL (2005) Selection of an empiric antibiotic regimen for hospital-acquired pneumonia using a unit and culture-type specific antibiogram. J Intensive Care Med. 20(5):296–301
    • View reference on PubMed
    • View reference on publisher's website
  114. Kaufman D, Haas CE, Edinger R, Hollick G (1998) Antibiotic susceptibility in the surgical intensive care unit compared with the hospital-wide antibiogram. Arch Surg 133(10):1041–1045
    • View reference on PubMed
    • View reference on publisher's website
  115. Kerremans JJ, Verbrugh HA, Vos MC (2012) Frequency of microbiologically correct antibiotic therapy increased by infectious disease consultations and microbiological results. J Clin Microbiol 50(6):2066–2068
    • View reference on PubMed
    • View reference on publisher's website
  116. Raineri E, Pan A, Mondello P, Acquarolo A, Candiani A, Crema L (2008) Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control 36(4):283–290
    • View reference on PubMed
    • View reference on publisher's website
  117. Bai AD, Showler A, Burry L et al (2015) Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis 60(10):1451–1461
    • View reference on PubMed
  118. Guo Y, Gao W, Yang H, Ma C, Sui S (2016) De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: a meta-analysis. Heart Lung 45(5):454–459
    • View reference on PubMed
    • View reference on publisher's website
  119. Bernard GR, Vincent JL, Laterre P et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10):699–709
    • View reference on PubMed
    • View reference on publisher's website
  120. Klein Klouwenberg PM, Cremer OL, van Vught LA et al (2015) Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care 19:319
    • View reference on PubMed
    • View reference on publisher's website
  121. Working Gropu IAP/APA Acute Pancreatitis Guidelines (2013) IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 13(4):e1–e15
    • View reference on publisher's website
  122. Wittau M, Mayer B, Scheele J, Henne-Bruns D, Dellinger EP, Isenmann R (2011) Systematic review and meta-analysis of antibiotic prophylaxis in severe acute pancreatitis. Scand J Gastroenterol 46(3):261–270
    • View reference on PubMed
    • View reference on publisher's website
  123. Avni T, Levcovich A, Ad-El DD, Leibovici L, Paul M (2010) Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ 340:c241
    • View reference on PubMed
    • View reference on publisher's website
  124. Barajas‐Nava LA, López‐Alcalde J, Roqué i Figuls M, Solà I, Bonfill Cosp X (2013) Antibiotic prophylaxis for preventing burn wound infection. Cochrane Database Syst Rev 6:CD008738
  125. Chelluri L, Jastremski MS (1987) Inadequacy of standard aminoglycoside loading doses in acutely ill patients. Crit Care Med 15(12):1143–1145
    • View reference on PubMed
    • View reference on publisher's website
  126. Pletz M, Bloos F, Burkhardt O et al (2010) Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock. Intensive Care Med 36(6):979–983
  127. Van Zanten AR, Polderman KH, van Geijlswijk IM, van der Meer GY, Schouten MA, Girbes AR (2008) Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study. J Crit Care 23(3):422–430
    • View reference on PubMed
    • View reference on publisher's website
  128. Blot S, Koulenti D, Akova M et al (2014) Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study. Crit Care 18(3):1–12
    • View reference on publisher's website
  129. Moore RD, Smith CR, Lietman PS (1984) Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med 77(4):657–662
    • View reference on PubMed
    • View reference on publisher's website
  130. Men P, Li HB, Zhai SD, Zhao RS (2016) Association between the AUC0-24/MIC ratio of vancomycin and its clinical effectiveness: a systematic review and meta-analysis. PLoS One 11(1):e0146224
    • View reference on PubMed
    • View reference on publisher's website
  131. Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ (2004) Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43(13):925–942
    • View reference on PubMed
    • View reference on publisher's website
  132. Zelenitsky S, Rubinstein E, Ariano R et al (2013) Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock. Int J Antimicrob Agents 41(3):255–260
    • View reference on PubMed
    • View reference on publisher's website
  133. Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham MC, Schentag JJ (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother (Bethesda). 37(5):1073–1081
    • View reference on publisher's website
  134. Preston SL, Drusano GL, Berman AL et al (1998) Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 279(2):125–129
    • View reference on PubMed
    • View reference on publisher's website
  135. Drusano GL, Preston SL, Fowler C, Corrado M, Weisinger B, Kahn J (2004) Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis 189(9):1590–1597
    • View reference on PubMed
    • View reference on publisher's website
  136. Kashuba AD, Nafziger AN, Drusano GL, Bertino JS Jr (1999) Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria. Antimicrob Agents Chemother (Bethesda). 43(3):623–629
  137. Schentag JJ, Smith IL, Swanson DJ et al (1984) Role for dual individualization with cefmenoxime. Am J Med 77(6A):43–50
    • View reference on PubMed
    • View reference on publisher's website
  138. Crandon JL, Bulik CC, Kuti JL, Nicolau DP (2010) Clinical pharmacodynamics of cefepime in patients infected with pseudomonas aeruginosa. Antimicrob Agents Chemother (Bethesda). 54(3):1111–1116
    • View reference on publisher's website
  139. McKinnon PS, Paladino JA, Schentag JJ (2008) Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T > MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents 31(4):345–351
    • View reference on PubMed
    • View reference on publisher's website
  140. Roberts JA, Abdul-Aziz MH, Davis JS et al (2016) Continuous versus intermittent beta-lactam infusion in severe sepsis. a meta-analysis of individual patient data from randomized trials. Am J Respir Crit Care Med 194(6):681–691
    • View reference on PubMed
    • View reference on publisher's website
  141. Barza M, Ioannidis JP, Cappelleri JC, Lau J (1996) Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 312(7027):338–344
    • View reference on PubMed
    • View reference on publisher's website
  142. Hatala R, Dinh T, Cook DJ (1996) Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann Intern Med 124(8):717–725
    • View reference on PubMed
    • View reference on publisher's website
  143. Zelenitsky SA, Ariano RE (2010) Support for higher ciprofloxacin AUC 24/MIC targets in treating Enterobacteriaceae bloodstream infection. J Antimicrob Chemother 65(8):1725–1732
    • View reference on PubMed
    • View reference on publisher's website
  144. Dunbar LM, Wunderink RG, Habib MP et al (2003) High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 37(6):752–760
    • View reference on PubMed
    • View reference on publisher's website
  145. Rybak M, Lomaestro B, Rotschafer J et al (2009) Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 49(3):325–327
    • View reference on PubMed
    • View reference on publisher's website
  146. Matsumoto K, Takesue Y, Ohmagari N et al (2013) Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. J Infect Chemother. 19(3):365–380
    • View reference on PubMed
    • View reference on publisher's website
  147. Steinmetz T, Eliakim-Raz N, Goldberg E, Leibovici L, Yahav D (2015) Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis. Clin Microbiol Infect 21(7):665–673
    • View reference on PubMed
    • View reference on publisher's website
  148. Mohamed AF, Karaiskos I, Plachouras D et al (2012) Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill. Antimicrob Agents Chemother 56(8):4241–4249
    • View reference on PubMed
    • View reference on publisher's website
  149. Pea F, Brollo L, Viale P, Pavan F, Furlanut M (2003) Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose. J Antimicrob Chemother 51(4):971–975
    • View reference on PubMed
    • View reference on publisher's website
  150. Pea F, Viale P (2009) Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock—does the dose matter? Crit Care 13(3):214
    • View reference on PubMed
    • View reference on publisher's website
  151. Wang JT, Fang CT, Chen YC, Chang SC (2001) Necessity of a loading dose when using vancomycin in critically ill patients. J Antimicrob Chemother 47(2):246
    • View reference on PubMed
    • View reference on publisher's website
  152. Kumar A (2014) An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy. Virulence 5(1):80–97
    • View reference on PubMed
    • View reference on publisher's website
  153. Rhodes NJ, MacVane SH, Kuti JL, Scheetz MH (2014) Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes. Clin Infect Dis 59(6):905–907
    • View reference on PubMed
    • View reference on publisher's website
  154. Lodise TP, Lomaestro BM, Drusano GL (2007) Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis 44:357–363
    • View reference on PubMed
    • View reference on publisher's website
  155. Yost RJ, Cappelletty DM, Bennett JH et al (2011) The retrospective cohort of extended-infusion piperacillin-tazobactam (RECEIPT) study: a multicenter study. Pharmacotherapy. 31(8):767–775
    • View reference on PubMed
    • View reference on publisher's website
  156. Falagas ME, Tansarli GS, Ikawa K, Vardakas KZ (2013) Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clin Infect Dis 56(2):272–282
    • View reference on PubMed
    • View reference on publisher's website
  157. Yusuf E, Spapen H, Piérard D (2014) Prolonged vs intermittent infusion of piperacillin/tazobactam in critically ill patients: a narrative and systematic review. J Crit Care 29(6):1089–1095
    • View reference on PubMed
    • View reference on publisher's website
  158. Mah GT, Mabasa VH, Chow I, Ensom MH (2012) Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review. Ann Pharmacother 46(2):265–275
    • View reference on PubMed
    • View reference on publisher's website
  159. Roberts JA, Abdul-Aziz MH, Lipman J et al (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 14(6):498–509
    • View reference on PubMed
    • View reference on publisher's website
  160. Baptista JP, Sousa E, Martins PJ, Pimentel JM (2012) Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents 39(5):420–423
    • View reference on PubMed
    • View reference on publisher's website
  161. Hobbs AL, Shea KM, Roberts KM, Daley MJ (2015) Implications of augmented renal clearance on drug dosing in critically ill patients: a focus on antibiotics. Pharmacotherapy. 35(11):1063–1075
    • View reference on PubMed
    • View reference on publisher's website
  162. Udy AA, Varghese JM, Altukroni M et al (2012) Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 142(1):30–39
    • View reference on PubMed
    • View reference on publisher's website
  163. Blot S, Koulenti D, Akova M et al (2014) Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study. Crit Care 18(3):R99
    • View reference on PubMed
    • View reference on publisher's website
  164. Roberts JA, Paul SK, Akova M et al (2014) DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58(8):1072–1083
    • View reference on PubMed
    • View reference on publisher's website
  165. Taccone FS, Laterre PF, Spapen H et al (2010) Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock. Crit Care 14(2):R53
    • View reference on PubMed
    • View reference on publisher's website
  166. Rea RS, Capitano B, Bies R, Bigos KL, Smith R, Lee H (2008) Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit 30(6):674–681
    • View reference on PubMed
    • View reference on publisher's website
  167. Kumar A, Safdar N, Kethireddy S, Chateau D (2010) A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study. Crit Care Med 38(8):1651–1665
    • View reference on PubMed
    • View reference on publisher's website
  168. Kumar A, Zarychanski R, Light B et al (2010) Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 38(9):1773–1785
    • View reference on PubMed
    • View reference on publisher's website
  169. Al-Hasan MN, Wilson JW, Lahr BD et al (2009) Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob Agents Chemother (Bethesda). 53(4):1386–1394
    • View reference on publisher's website
  170. Delannoy PY, Boussekey N, Alfandari S et al (2012) Impact of combination therapy with aminoglycosides on the outcome of ICU-acquired bacteraemias. Eur J Clin Microbiol Infect Dis 31(9):2293–2299
    • View reference on PubMed
    • View reference on publisher's website
  171. Diaz-Martin A, Martinez-Gonzalez ML, Ferrer R et al (2012) Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality. Crit Care 16(6):R223
    • View reference on PubMed
    • View reference on publisher's website
  172. Martin-Loeches I, Lisboa T, Rodriguez A et al (2010) Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 36(4):612–620
  173. Brunkhorst FM, Oppert M, Marx G et al (2012) Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA 307(22):2390–2399
    • View reference on PubMed
    • View reference on publisher's website
  174. Safdar N, Handelsman J, Maki DG (2004) Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis. 4(8):519–527
    • View reference on PubMed
    • View reference on publisher's website
  175. Paul M, Silbiger I, Grozinsky S, Soares-Weiser K, Leibovici L (2006) Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 1:CD003344
  176. Rodriguez A, Mendia A, Sirvent JM et al (2007) Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med 35(6):1493–1498
    • View reference on PubMed
    • View reference on publisher's website
  177. Baddour LM, Yu VL, Klugman KP et al (2004) Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 170:440–444
    • View reference on PubMed
    • View reference on publisher's website
  178. Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR (1989) Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 87(5):540–546
    • View reference on PubMed
    • View reference on publisher's website
  179. Tumbarello M, Viale P, Viscoli C et al (2012) Predictors of mortality in bloodstream infections caused by KPC-producing Klebsiella pneumoniae: importance of combination therapy. Clin Infect Dis 55(7):943
    • View reference on PubMed
    • View reference on publisher's website
  180. Bass SN, Bauer SR, Neuner EA, Lam SW (2015) Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia. Antimicrob Agents Chemother (Bethesda). 59(7):3748–3753
    • View reference on publisher's website
  181. Poulikakos P, Tansarli G, Falagas M (2014) Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review. Eur J Clin Microbiol Infect Dis 33(10):1675–1685
    • View reference on PubMed
    • View reference on publisher's website
  182. Falagas ME, Lourida P, Poulikakos P, Rafailidis PI, Tansarli GS (2014) Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother (Bethesda). 58(2):654–663
    • View reference on publisher's website
  183. Hu Y, Li L, Li W et al (2013) Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies. Int J Antimicrob Agents 42(6):492–496
    • View reference on PubMed
    • View reference on publisher's website
  184. Vardakas KZ, Tansarli GS, Bliziotis IA, Falagas ME (2013) β-lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis. Int J Antimicrob Agents 41(4):301–310
    • View reference on PubMed
    • View reference on publisher's website
  185. Stevens DL, Tanner MH, Winship J et al (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321(1):1–7
    • View reference on PubMed
    • View reference on publisher's website
  186. Zimbelman J, Palmer A, Todd J (1999) Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 18(12):1096–1100
    • View reference on PubMed
    • View reference on publisher's website
  187. Paul M, Soares-Weiser K, Leibovici L (2003) ß-lactam monotherapy versus ß-lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. Br Med J 326(7399):1111–1118
    • View reference on publisher's website
  188. Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56–e93
    • View reference on PubMed
    • View reference on publisher's website
  189. Gomes Silva BN, Andriolo RB, Atallah AN, Salomão R (2010) De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 12:CD007934
  190. Morel J, Casoetto J, Jospé R et al (2010) De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care 14(6):R225
    • View reference on PubMed
    • View reference on publisher's website
  191. Joung MK, Lee JA, Moon SY et al (2011) Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care 15(2):R79
    • View reference on PubMed
    • View reference on publisher's website
  192. Leone M, Bechis C, Baumstarck K et al (2014) De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 40(10):1399–1408
  193. Riccio LM, Popovsky KA, Hranjec T et al (2014) Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections. Surg Infect. 15(4):417–424
    • View reference on publisher's website
  194. Aarts MA, Brun-Buisson C, Cook DJ et al (2007) Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome? Intensive Care Med 33(8):1369–1378
  195. Stevens V, Dumyati G, Fine LS, Fisher SG, Van Wijngaarden E (2011) Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 53(1):42–48
    • View reference on PubMed
    • View reference on publisher's website
  196. Goossens H (2009) Antibiotic consumption and link to resistance. Clin Microbiol Infect 15(Suppl 3):12–15
    • View reference on PubMed
    • View reference on publisher's website
  197. Chastre J, Wolff M, Fagon JY et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290(19):2588–2598
    • View reference on PubMed
    • View reference on publisher's website
  198. Choudhury G, Mandal P, Singanayagam A, Akram AR, Chalmers JD, Hill AT (2011) Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia-a propensity-adjusted analysis. Clin Microbiol Infect 17(12):1852–1858
    • View reference on PubMed
    • View reference on publisher's website
  199. Pugh R, Grant C, Cooke RP, Dempsey G (2015) Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults. Cochrane Database Syst Rev 8:CD007577
  200. Sawyer RG, Claridge JA, Nathens AB et al (2015) Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 372(21):1996–2005
    • View reference on PubMed
    • View reference on publisher's website
  201. Eliakim-Raz N, Yahav D, Paul M, Leibovici L (2013) Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection—7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 68(10):2183–2191
    • View reference on PubMed
  202. Rattan R, Allen CJ, Sawyer RG et al (2016) Patients with complicated intra-abdominal infection presenting with sepsis do not require longer duration of antimicrobial therapy. J Am Coll Surg 222(4):440–446
    • View reference on PubMed
    • View reference on publisher's website
  203. Hepburn MJ, Dooley DP, Skidmore PJ, Ellis MW, Starnes WF, Hasewinkle WC (2004) Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med 164(15):1669–1674
    • View reference on PubMed
    • View reference on publisher's website
  204. Chaudhry ZI, Nisar S, Ahmed U, Ali M (2000) Short course of antibiotic treatment in spontaneous bacterial peritonitis: a randomized controlled study. J Coll Physicians Surg Pak 10(8):284–288
  205. Jack L, Bal AM, Harte S, Collier A (2016) International guidelines: the need to standardize the management of candidaemia. Infect Dis (Lond). 48(11–12):779–781
    • View reference on PubMed
    • View reference on publisher's website
  206. Baddour LM, Wilson WR, Bayer AS et al (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435–1486
    • View reference on PubMed
    • View reference on publisher's website
  207. Habib G, Lancellotti P, Antunes MJ et al (2015) 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J 36(44):3075–3128
    • View reference on PubMed
    • View reference on publisher's website
  208. Weiss CH, Moazed F, McEvoy CA et al (2011) Prompting physicians to address a daily checklist and process of care and clinical outcomes: a single-site study. Am J Respir Crit Care Med 184(6):680
    • View reference on PubMed
    • View reference on publisher's website
  209. Aguado JM, Vázquez L, Fernández-Ruiz M et al (2015) Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial. Clin Infect Dis 60(3):405–414
    • View reference on PubMed
    • View reference on publisher's website
  210. Hou TY, Wang SH, Liang SX, Jiang WX, Luo DD, Huang DH (2015) The screening performance of serum 1,3-beta-D-glucan in patients with invasive fungal diseases: a meta-analysis of prospective cohort studies. PLoS One 10(7):e0131602
    • View reference on PubMed
    • View reference on publisher's website
  211. Schuetz P, Briel M, Christ-Crain M et al (2012) Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 55(5):651–662
    • View reference on PubMed
    • View reference on publisher's website
  212. Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G (2012) An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med 38(6):940–949
  213. Prkno A, Wacker C, Brunkhorst FM, Schlattmann P (2013) Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock—a systematic review and meta-analysis. Crit Care 17(6):R291
    • View reference on PubMed
    • View reference on publisher's website
  214. Westwood M, Ramaekers B, Whiting P et al (2015) Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis. Health Technol Assess 19(96):v–xxv, 1–236
  215. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 13(5):426–435
    • View reference on PubMed
    • View reference on publisher's website
  216. Soni NJ, Samson DJ, Galaydick JL et al (2013) Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis. J Hosp Med. 8(9):530–540
    • View reference on PubMed
    • View reference on publisher's website
  217. De Jong E, van Oers JA, Beishuizen A et al (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 16(7):819–827
    • View reference on PubMed
    • View reference on publisher's website
  218. Lesprit P, Landelle C, Girou E, Brun-Buisson C (2010) Reassessment of intravenous antibiotic therapy using a reminder or direct counselling. J Antimicrob Chemother 65(4):789–795
    • View reference on PubMed
    • View reference on publisher's website
  219. Paul M, Dickstein Y, Raz-Pasteur A (2016) Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. Clin Microbiol Infect 22(12):960–967
    • View reference on PubMed
    • View reference on publisher's website
  220. Schuetz P, Kutz A, Grolimund E et al (2014) Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial. Int J Cardiol 175(3):464–472
    • View reference on PubMed
    • View reference on publisher's website
  221. Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld AB (2015) The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect 21(5):474–481
    • View reference on PubMed
    • View reference on publisher's website
  222. Jimenez MF, Marshall JC (2001) Source control in the management of sepsis. Intensive Care Med 27:S49–S62
  223. Azuhata T, Kinoshita K, Kawano D et al (2014) Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care 18(3):R87
    • View reference on PubMed
    • View reference on publisher's website
  224. Bloos F, Thomas-Rüddel D, Rüddel H et al (2014) Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care 18(2):1
    • View reference on publisher's website
  225. Moss RL, Musemeche CA, Kosloske AM (1996) Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg 31(8):1142–1146
    • View reference on PubMed
    • View reference on publisher's website
  226. Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO (2003) Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85(8):1454–1460
    • View reference on PubMed
    • View reference on publisher's website
  227. Chao WN, Tsai CF, Chang HR et al (2013) Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. Am J Surg 206(1):32–39
    • View reference on PubMed
    • View reference on publisher's website
  228. Buck DL, Vester-Andersen M, Møller MH, Danish Clinical Register of Emergency Surgery (2013) Surgical delay is a critical determinant of survival in perforated peptic ulcer. Br J Surg 100(8):1045–1049
    • View reference on PubMed
    • View reference on publisher's website
  229. Karvellas CJ, Abraldes JG, Zepeda-Gomez S et al (2016) The impact of delayed biliary decompression and antimicrobial therapy in 260 patients with cholangitis-associated septic shock. Aliment Pharmacol Ther 44(7):755–766
    • View reference on PubMed
    • View reference on publisher's website
  230. Maitland K, Kiguli S, Opoka RO et al (2011) Mortality after fluid bolus in African children with severe infection. N Engl J Med 364(26):2483–2495
    • View reference on PubMed
    • View reference on publisher's website
  231. Acheampong A, Vincent JL (2015) A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care 19:251
    • View reference on PubMed
    • View reference on publisher's website
  232. Brotfain E, Koyfman L, Toledano R et al (2016) Positive fluid balance as a major predictor of clinical outcome of patients with sepsis/septic shock after ICU discharge. Am J Emerg Med 34(11):2122–2126
    • View reference on PubMed
    • View reference on publisher's website
  233. Mitchell KH, Carlbom D, Caldwell E, Leary PJ, Himmelfarb J, Hough CL (2015) Volume overload: prevalence, risk factors, and functional outcome in survivors of septic shock. Ann Am Thorac Soc. 12(12):1837–1844
    • View reference on PubMed
    • View reference on publisher's website
  234. De Oliveira FS, Freitas FG, Ferreira EM et al (2015) Positive fluid balance as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock. J Crit Care 30(1):97–101
    • View reference on PubMed
    • View reference on publisher's website
  235. Malbrain ML, Marik PE, Witters I et al (2014) Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 46(5):361–380
    • View reference on PubMed
    • View reference on publisher's website
  236. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M (2012) Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308(15):1566–1572
    • View reference on PubMed
    • View reference on publisher's website
  237. Rochwerg B, Alhazzani W, Sindi A et al (2014) Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161(5):347–355
    • View reference on PubMed
    • View reference on publisher's website
  238. Young P, Bailey M, Beasley R et al (2015) Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA 314(16):1701–1710
    • View reference on PubMed
    • View reference on publisher's website
  239. Finfer S, Norton R, Bellomo R, Boyce N, French J, Myburgh J (2004) The SAFE study: saline vs. albumin for fluid resuscitation in the critically ill. Vox Sang 87(Suppl 2):123–131
    • View reference on PubMed
    • View reference on publisher's website
  240. Delaney AP, Dan A, McCaffrey J, Finfer S (2011) The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 39(2):386–391
    • View reference on PubMed
    • View reference on publisher's website
  241. Rochwerg B, Alhazzani W, Gibson A et al (2015) Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med 41(9):1561–1571
  242. Xu JY, Chen QH, Xie JF et al (2014) Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials. Crit Care 18(6):702
    • View reference on PubMed
    • View reference on publisher's website
  243. Uhlig C, Silva PL, Deckert S, Schmitt J, de Abreu MG (2014) Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care 18(1):R10
    • View reference on PubMed
    • View reference on publisher's website
  244. Patel A, Laffan MA, Waheed U, Brett SJ (2014) Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ 349:g4561
    • View reference on PubMed
    • View reference on publisher's website
  245. Jiang L, Jiang S, Zhang M, Zheng Z, Ma Y (2014) Albumin versus other fluids for fluid resuscitation in patients with sepsis: a meta-analysis. PLoS One 9(12):e114666
    • View reference on PubMed
    • View reference on publisher's website
  246. Boldt J, Heesen M, Muller M, Pabsdorf M, Hempelmann G (1996) The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 83(2):254–261
    • View reference on PubMed
    • View reference on publisher's website
  247. Boldt J, Heesen M, Welters I, Padberg W, Martin K, Hempelmann G (1995) Does the type of volume therapy influence endothelial-related coagulation in the critically ill? Br J Anaesth 75(6):740–746
    • View reference on PubMed
    • View reference on publisher's website
  248. Boldt J, Muller M, Heesen M, Heyn O, Hempelmann G (1996) Influence of different volume therapies on platelet function in the critically ill. Intensive Care Med 22(10):1075–1081
  249. Caironi P, Tognoni G, Masson S et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370(15):1412–1421
    • View reference on PubMed
    • View reference on publisher's website
  250. Haase N, Perner A, Hennings LI et al (2013) Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839
    • View reference on PubMed
    • View reference on publisher's website
  251. Moeller C, Fleischmann C, Thomas-Rueddel D et al (2016) How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care 35:75–83
    • View reference on PubMed
    • View reference on publisher's website
  252. Day NP, Phu NH, Bethell DP et al (1996) The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 348(9022):219–223
    • View reference on PubMed
    • View reference on publisher's website
  253. De Backer D, Creteur J, Silva E, Vincent JL (2003) Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 31(6):1659–1667
    • View reference on PubMed
    • View reference on publisher's website
  254. Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 103(6):1826–1831
    • View reference on PubMed
    • View reference on publisher's website
  255. Martin C, Viviand X, Leone M, Thirion X (2000) Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28(8):2758–2765
    • View reference on PubMed
    • View reference on publisher's website
  256. Bollaert PE, Bauer P, Audibert G, Lambert H, Larcan A (1990) Effects of epinephrine on hemodynamics and oxygen-metabolism in dopamine-resistant septic shock. Chest 98(4):949–953
    • View reference on PubMed
    • View reference on publisher's website
  257. Levy B, Bollaert PE, Charpentier C et al (1997) Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 23(3):282–287
  258. Zhou SX, Qiu HB, Huang YZ, Yang Y, Zheng RQ (2002) Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. Acta Pharmacol Sin 23(7):654–658
    • View reference on PubMed
  259. Mackenzie SJ, Kapadia F, Nimmo GR, Armstrong IR, Grant IS (1991) Adrenaline in treatment of septic shock: effects on hemodynamics and oxygen-transport. Intensive Care Med 17(1):36–39
  260. Moran JL, O’Fathartaigh MS, Peisach AR, Chapman MJ, Leppard P (1993) Epinephrine as an inotropic agent in septic shock: a dose-profile analysis. Crit Care Med 21(1):70–77
    • View reference on PubMed
    • View reference on publisher's website
  261. Yamazaki T, Shimada Y, Taenaka N, Oshumi H, Takezawa J, Yoshiya I (1982) Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis. Crit Care Med 10(7):432–435
    • View reference on PubMed
    • View reference on publisher's website
  262. Regnier B, Rapin M, Gory G, Lemaire F, Teisseire B, Harari A (1977) Haemodynamic effects of dopamine in septic shock. Intensive Care Med 3(2):47–53
  263. Beck GCh, Brinkkoetter P, Hanusch C et al (2004) Clinical review: immunomodulatory effects of dopamine in general inflammation. Crit Care 8(6):485–491
    • View reference on PubMed
    • View reference on publisher's website
  264. Avni T, Lador A, Lev S, Leibovici L, Paul M, Grossman A (2015) Vasopressors for the treatment of septic shock: systematic review and meta-analysis. PLoS One 10(8):e0129305
    • View reference on PubMed
    • View reference on publisher's website
  265. Myburgh JA, Higgins A, Jovanovska A et al (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34(12):2226–2234
  266. Landry DW, Levin HR, Gallant EM et al (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95(5):1122–1125
    • View reference on PubMed
    • View reference on publisher's website
  267. Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96(3):576–582
    • View reference on PubMed
    • View reference on publisher's website
  268. Dunser MW, Mayr AJ, Ulmer H et al (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107(18):2313–2319
    • View reference on PubMed
    • View reference on publisher's website
  269. Lauzier F, Levy B, Lamarre P, Lesur O (2006) Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 32(11):1782–1789
  270. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA (2001) The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27(8):1416–1421
  271. Malay MB, Ashton RC, Landry DW, Townsend RN (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47(4):699–703
    • View reference on PubMed
    • View reference on publisher's website
  272. O’Brien A, Clapp L, Singer M (2002) Terlipressin for norepinephrine-resistant septic shock. Lancet 359(9313):1209–1210
    • View reference on PubMed
    • View reference on publisher's website
  273. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D (2003) Circulating vasopressin levels in septic shock. Crit Care Med 31(6):1752–1758
    • View reference on PubMed
    • View reference on publisher's website
  274. Russell JA, Walley KR, Singer J et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358(9):877–887
    • View reference on PubMed
    • View reference on publisher's website
  275. Dunser MW, Mayr AJ, Tur A et al (2003) Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med 31(5):1394–1398
    • View reference on PubMed
    • View reference on publisher's website
  276. Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509–518
    • View reference on PubMed
    • View reference on publisher's website
  277. Albanese J, Leone M, Delmas A, Martin C (2005) Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med 33(9):1897–1902
    • View reference on PubMed
    • View reference on publisher's website
  278. Morelli A, Ertmer C, Lange M et al (2008) Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth 100(4):494–503
    • View reference on PubMed
    • View reference on publisher's website
  279. Morelli A, Ertmer C, Rehberg S et al (2009) Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 13(4):R130
    • View reference on PubMed
    • View reference on publisher's website
  280. Zhou F, Mao Z, Zeng X et al (2015) Vasopressors in septic shock: a systematic review and network meta-analysis. Ther Clin Risk Manag 11:1047–1059
    • View reference on PubMed
    • View reference on publisher's website
  281. De Backer D, Aldecoa C, Njimi H, Vincent JL (2012) Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 40(3):725–730
    • View reference on PubMed
    • View reference on publisher's website
  282. De Backer D, Biston P, Devriendt J et al (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362(9):779–789
    • View reference on PubMed
    • View reference on publisher's website
  283. Parker MM, Shelhamer JH, Bacharach SL et al (1984) Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483–490
    • View reference on PubMed
    • View reference on publisher's website
  284. Gattinoni L, Brazzi L, Pelosi P et al (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333(16):1025–1032
    • View reference on PubMed
    • View reference on publisher's website
  285. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330(24):1717–1722
    • View reference on PubMed
    • View reference on publisher's website
  286. Hollenberg SM, Ahrens TS, Annane D et al (2004) Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32(9):1928–1948
    • View reference on PubMed
    • View reference on publisher's website
  287. Annane D, Vignon P, Renault A et al (2007) Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370(9588):676–684
    • View reference on PubMed
    • View reference on publisher's website
  288. ProCess Investigators, Yealy DM, Kellum JA et al (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370(18):1683–1693
  289. ARISE Investigators, Anzics Clinical Trials Group, Peake SL et al (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371(16):1496–1506
  290. Barton P, Garcia J, Kouatli A et al (1996) Hemodynamic effects of IV milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 109(5):1302–1312
    • View reference on PubMed
    • View reference on publisher's website
  291. Morelli A, Teboul JL, Maggiore SM et al (2006) Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 34(9):2287–2293
    • View reference on PubMed
    • View reference on publisher's website
  292. Morelli A, De Castro S, Teboul JL et al (2005) Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31(5):638–644
  293. Gordon AC, Perkins GD, Singer M et al Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med. doi:10.1056/NEJMoa1609409
  294. Cohn JN (1967) Blood pressure measurement in shock. Mechanism of inaccuracy in ausculatory and palpatory methods. JAMA 199(13):118–122
    • View reference on PubMed
    • View reference on publisher's website
  295. Hollenberg SM, Parrillo JE (1997) Shock. In: Braunwald E, Isselbacher KJ, Wilson JD et al (eds) Harrison’s principles of internal medicine, 14th edn. McGraw-Hill, New York, pp 214–222
  296. Scheer B, Perel A, Pfeiffer UJ (2002) Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care 6(3):199–204
    • View reference on PubMed
    • View reference on publisher's website
  297. Gu WJ, Wu XD, Wang F, Ma ZL, Gu XP (2016) Ultrasound guidance facilitates radial artery catheterization: a meta-analysis with trial sequential analysis of randomized controlled trials. Chest 149(1):166–179
    • View reference on PubMed
    • View reference on publisher's website
  298. O’Horo JC, Maki DG, Krupp AE, Safdar N (2014) Arterial catheters as a source of bloodstream infection: a systematic review and meta-analysis. Crit Care Med 42(6):1334–1339
    • View reference on PubMed
    • View reference on publisher's website
  299. Annane D, Bellissant E, Bollaert PE et al (2009) Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 301(22):2362–2375
    • View reference on PubMed
    • View reference on publisher's website
  300. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26(4):645–650
    • View reference on PubMed
    • View reference on publisher's website
  301. Briegel J, Forst H, Haller M et al (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27(4):723–732
    • View reference on PubMed
    • View reference on publisher's website
  302. Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358(2):111–124
    • View reference on PubMed
    • View reference on publisher's website
  303. Sligl WI, Milner DA Jr, Sundar S, Mphatswe W, Majumdar SR (2009) Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis 49(1):93–101
    • View reference on PubMed
    • View reference on publisher's website
  304. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y (2015) Corticosteroids for treating sepsis. Cochrane Database Syst Rev 12:CD002243
  305. Volbeda M, Wetterslev J, Gluud C, Zijlstra JG, van der Horst IC, Keus F (2015) Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 41(7):1220–1234
  306. Annane D, Sebille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288(7):862–871
    • View reference on PubMed
    • View reference on publisher's website
  307. Briegel J, Sprung CL, Annane D et al (2009) Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock. Intensive Care Med 35(12):2151–2156
  308. Allolio B, Dorr H, Stuttmann R, Knorr D, Engelhardt D, Winkelmann W (1985) Effect of a single bolus of etomidate upon 8 major corticosteroid hormones and plasma ACTH. Clin Endocrinol 22(3):281–286
    • View reference on publisher's website
  309. Jabre P, Combes X, Lapostolle F et al (2009) Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 374(9686):293–300
    • View reference on PubMed
    • View reference on publisher's website
  310. Oppert M, Schindler R, Husung C et al (2005) Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 33(11):2457–2464
    • View reference on PubMed
    • View reference on publisher's website
  311. Yildiz O, Doganay M, Aygen B, Güven M, Kelestimur F, Tutuû A (2002) Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care 6(3):251–259
    • View reference on PubMed
    • View reference on publisher's website
  312. Keh D, Boehnke T, Weber-Cartens S et al (2003) Immunologic and hemodynamic effects of “low-dose” hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167(4):512–520
    • View reference on PubMed
    • View reference on publisher's website
  313. Huh JW, Choi H-S, Lim C-M et al (2011) Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3 days with 7 days. Respirology 16(7):1088–1095
    • View reference on PubMed
    • View reference on publisher's website
  314. Keh D, Trips E, Marx G et al (2016) Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA 316(17):1775–1785
    • View reference on PubMed
    • View reference on publisher's website
  315. Weber-Carstens S, Deja M, Bercker S et al (2007) Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients. Intensive Care Med 33(4):730–733
  316. Holst LB, Haase N, Wetterslev J et al (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371(15):1381–1391
    • View reference on PubMed
    • View reference on publisher's website
  317. Corwin HL, Gettinger A, Pearl RG et al (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288(22):2827–2835
    • View reference on PubMed
    • View reference on publisher's website
  318. Corwin HL, Gettinger A, Rodriguez RM et al (1999) Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 27(11):2346–2350
    • View reference on PubMed
    • View reference on publisher's website
  319. Liumbruno G, Bennardello F, Lattanzio A et al (2009) Recommendations for the transfusion of plasma and platelets. Blood Transfus. 7(2):132–137
    • View reference on PubMed
  320. British Committee for Standards in Haematology (2003) Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol 122(1):10–23
    • View reference on publisher's website
  321. Diedrich B, Remberger M, Shanwell A, Svahn BM, Ringdén O (2005) A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 × 10(9) per L versus 30 × 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion. 45(7):1064–1072
    • View reference on PubMed
    • View reference on publisher's website
  322. Kaufman RM, Djulbegovic B, Gernsheimer T et al (2015) Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 162(3):205–213
    • View reference on PubMed
    • View reference on publisher's website
  323. Schiffer CA, Anderson KC, Bennett CL et al (2001) Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19(5):1519–1538
    • View reference on PubMed
  324. Stanworth SJ, Estcourt LJ, Llewelyn CA, Murphy MF, Wood EM, TOPPS Study Investigators (2014) Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial. Transfusion. 54(10):2385–2393
    • View reference on PubMed
    • View reference on publisher's website
  325. Stanworth SJ, Estcourt LJ, Powter G et al (2013) A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 368(19):1771–1780
    • View reference on PubMed
    • View reference on publisher's website
  326. Wandt H, Schaefer-Eckart K, Wendelin K et al (2012) Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 380(9850):1309–1316
    • View reference on PubMed
    • View reference on publisher's website
  327. Zumberg MS, del Rosario ML, Nejame CF et al (2002) A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. Biol Blood Marrow Transplant 8(10):569–576
    • View reference on PubMed
    • View reference on publisher's website
  328. Werdan K, Pilz G, Bujdoso O, Fraunberger P et al (2007) Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 35(12):2693–2701
    • View reference on PubMed
    • View reference on publisher's website
  329. Alejandria MM, Lansang MA, Dans LF, Mantaring JB 3rd (2013) Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev 9:CD001090
  330. Soares MO, Welton NJ, Harrison DA et al (2012) An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess 16(7):1–186
    • View reference on publisher's website
  331. Laupland KB, Kirkpatrick AW, Delaney A (2007) Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 35(12):2686–2692
    • View reference on PubMed
    • View reference on publisher's website
  332. Pildal J, Gotzsche PC (2004) Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis 39(1):38–46
    • View reference on PubMed
    • View reference on publisher's website
  333. Kreyrnann KG, de Heer G, Nierhaus A, Kluge S (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 35(12):2677–2685
    • View reference on publisher's website
  334. Shankar-Hari M, Culshaw N, Post B et al (2015) Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis. Intensive Care Med 41(8):1393–1401
  335. Turgeon AF, Hutton B, Fergusson DA et al (2007) Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 146(3):193–203
    • View reference on PubMed
    • View reference on publisher's website
  336. Zhou F, Peng Z, Murugan R, Kellum JA (2013) Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med 41(9):2209–2220
    • View reference on PubMed
    • View reference on publisher's website
  337. Payen DM, Guilhot J, Launey Y et al (2015) Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 41(6):975–984
  338. Klein DJ, Foster D, Schorr CA, Kazempour K, Walker PM, Dellinger RP (2014) The EUPHRATES trial (evaluating the use of polymyxin B hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock): study protocol for a randomized controlled trial. Trials. 15:218
    • View reference on PubMed
    • View reference on publisher's website
  339. Livigni S, Bertolini G, Rossi C et al (2014) Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial. BMJ Open. 4(1):e003536
    • View reference on PubMed
    • View reference on publisher's website
  340. Allingstrup M, Wetterslev J, Ravn FB, Moller AM, Afshari A (2016) Antithrombin III for critically ill patients. Cochrane Database Syst Rev 2:CD005370
  341. Warren BL, Eid A, Singer P et al (2001) High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286(15):1869–1878
    • View reference on PubMed
    • View reference on publisher's website
  342. Vincent JL, Ramesh MK, Ernest D et al (2013) A randomized, double-blind, placebo-controlled, phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med 41(9):2069–2079
    • View reference on PubMed
    • View reference on publisher's website
  343. Yamakawa K, Ogura H, Fujimi S et al (2013) Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Intensive Care Med 39(4):644–652
  344. Zarychanski R, Abou-Setta AM, Kanji S et al (2015) The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med 43(3):511–518
    • View reference on PubMed
    • View reference on publisher's website
  345. Ranieri VM, Thompson BT, Barie PS et al (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366(22):2055–2064
    • View reference on PubMed
    • View reference on publisher's website
  346. Bernard GR, Artigas A, Brigham KL et al (1994) The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical-trial coordination. Am J Respir Crit Care Med 149(3):818–824
  347. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD et al (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307(23):2526–2533
  348. Amato MB, Barbas CS, Medeiros DM et al (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338(6):347–354
    • View reference on PubMed
    • View reference on publisher's website
  349. Brochard L, Roudot-Thoraval F, Roupie E et al (1998) Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. Am J Respir Crit Care Med 158(6):1831–1838
    • View reference on PubMed
    • View reference on publisher's website
  350. Brower RG, Matthay MA, Morris A et al (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342(18):1301–1308
    • View reference on publisher's website
  351. Brower RG, Shanholtz CB, Fessler HE et al (1999) Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27(8):1492–1498
    • View reference on PubMed
    • View reference on publisher's website
  352. Eichacker PQ, Gerstenberger EP, Banks SM, Cui XZ, Natanson C (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 166(11):1510–1514
    • View reference on PubMed
    • View reference on publisher's website
  353. Burns KEA, Adhikari NK, Slutsky AS et al (2011) Pressure and volume limited ventilation for the ventilatory management of patients with acute lung injury: a systematic review and meta-analysis. PLoS One 6(1):e14623
    • View reference on PubMed
    • View reference on publisher's website
  354. Putensen C, Theuerkauf N, Zinserling J, Wrigge H, Pelosi P (2009) Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Intern Med 151(8):566–576
    • View reference on PubMed
    • View reference on publisher's website
  355. Marini JJ, Gattinoni L (2004) Ventilatory management of acute respiratory distress syndrome: a consensus of two. Crit Care Med 32(1):250–255
    • View reference on PubMed
    • View reference on publisher's website
  356. Tobin MJ (2000) Culmination of an era in research on the acute respiratory distress syndrome. N Engl J Med 342(18):1360–1361
    • View reference on PubMed
    • View reference on publisher's website
  357. Hager DN, Krishnan JA, Hayden DL, Brower RG, ARDS Clinical Trials Network (2005) Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 172(10):1241–1245
    • View reference on PubMed
    • View reference on publisher's website
  358. Checkley W, Brower R, Korpak A, Thompson BT, Acute Respiratory Distress Syndrome Network Investigators (2008) Effects of a clinical trial on mechanical ventilation practices in patients with acute lung injury. Am J Respir Crit Care Med 177(11):1215–1222
    • View reference on PubMed
    • View reference on publisher's website
  359. Amato MB, Meade MO, Slutsky AS et al (2015) Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 372(8):747–755
    • View reference on PubMed
    • View reference on publisher's website
  360. Gattinoni L, Marcolin R, Caspani ML, Fumagalli R, Mascheroni D, Pesenti A (1985) Constant mean airway pressure with different patterns of positive pressure breathing during the adult respiratory distress syndrome. Bull Eur Physiopathol Respir. 21(3):275–279
    • View reference on PubMed
  361. Marini JJ, Ravenscraft SA (1992) Mean airway pressure: physiological determinants and clinical importance—Part 1: physiological determinants and measurements. Crit Care Med 20(10):1461–1472
    • View reference on PubMed
    • View reference on publisher's website
  362. Pesenti A, Marcolin R, Prato P, Borelli M, Riboni A, Gattinoni L (1985) Mean airway pressure vs positive end-expiratory pressure during mechanical ventilation. Crit Care Med 13(1):34–37
    • View reference on PubMed
    • View reference on publisher's website
  363. Brower RG, Lanken PN, MacIntyre N et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351(4):327–336
    • View reference on PubMed
    • View reference on publisher's website
  364. Meade MO, Cook DJ, Guyatt GH et al (2008) Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):637–645
    • View reference on PubMed
    • View reference on publisher's website
  365. Mercat A, Richard JC, Vielle B et al (2008) Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):646–655
    • View reference on PubMed
    • View reference on publisher's website
  366. Villar J, Kacmarek RM, Perez-Mendez L, Aguirre-Jaime A (2006) A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 34(5):1311–1318
    • View reference on PubMed
    • View reference on publisher's website
  367. Briel M, Meade M, Mercat A et al (2010) Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 303(9):865–873
    • View reference on PubMed
    • View reference on publisher's website
  368. Goligher EC, Kavanagh BP, Rubenfeld GD et al (2014) Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials. Am J Respir Crit Care Med 190(1):70–76
    • View reference on PubMed
    • View reference on publisher's website
  369. Talmor D, Sarge T, Malhotra A et al (2008) Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 359(20):2095–2104
    • View reference on PubMed
    • View reference on publisher's website
  370. Amato MB, Barbas CS, Medeiros DM et al (1995) Beneficial effects of the “open lung approach” with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med 152(6):1835–1846
    • View reference on PubMed
    • View reference on publisher's website
  371. Gattinoni L, Caironi P, Cressoni M et al (2006) Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 354(17):1775–1786
    • View reference on PubMed
    • View reference on publisher's website
  372. Pipeling MR, Fan E (2010) Therapies for refractory hypoxemia in acute respiratory distress syndrome. JAMA 304(22):2521–2527
    • View reference on PubMed
    • View reference on publisher's website
  373. Fan E, Wilcox ME, Brower RG et al (2008) Recruitment maneuvers for acute lung injury: a systematic review. Am J Respir Crit Care Med 178(11):1156–1163
    • View reference on PubMed
    • View reference on publisher's website
  374. Guerin C, Reignier J, Richard JC et al (2013) Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368(23):2159–2168
    • View reference on PubMed
    • View reference on publisher's website
  375. Beitler JR, Shaefi S, Montesi SB et al (2014) Prone positioning reduces mortality from acute respiratory distress syndrome in the low tidal volume era: a meta-analysis. Intensive Care Med 40(3):332–341
  376. Jolliet P, Bulpa P, Chevrolet JC (1998) Effects of the prone position on gas exchange and hemodynamics in severe acute respiratory distress syndrome. Crit Care Med 26(12):1977–1985
    • View reference on PubMed
    • View reference on publisher's website
  377. Lamm WJE, Graham MM, Albert RK (1994) Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 150(1):184–193
    • View reference on PubMed
    • View reference on publisher's website
  378. Stocker R (1997) Prone positioning and low-volume pressure-limited ventilation improve survival in patients with severe ARDS. Chest 111(4):1008
    • View reference on PubMed
    • View reference on publisher's website
  379. Guerin C, Gaillard S, Lemasson S et al (2004) Effect of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 292(19):2379–2387
    • View reference on PubMed
    • View reference on publisher's website
  380. Peek GJ, Mugford M, Tiruvoipati R (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698):1351–1363
    • View reference on PubMed
    • View reference on publisher's website
  381. Sud S, Sud M, Friedrich JO et al (2010) High frequency oscillation in patients with acute lung injury and acute respiratory distress syndrome (ARDS): systematic review and meta-analysis. BMJ 340:c2327
    • View reference on PubMed
    • View reference on publisher's website
  382. Noah MA, Peek GJ, Finney SJ et al (2011) Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A (H1N1). JAMA 306(15):1659–1668
    • View reference on PubMed
    • View reference on publisher's website
  383. Checkley W (2011) Extracorporeal membrane oxygenation as a first-line treatment strategy for ARDS: is the evidence sufficiently strong? JAMA 306(15):1703–1704
    • View reference on PubMed
    • View reference on publisher's website
  384. Ferguson ND, Cook DJ, Guyatt GH et al (2013) High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 368(9):795–805
    • View reference on PubMed
    • View reference on publisher's website
  385. Young D, Lamb SE, Shah S et al (2013) High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med 368(9):806–813
    • View reference on PubMed
    • View reference on publisher's website
  386. Meade MO, Cook DJ, Guyatt GH et al (2008) Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299(6):637–645
    • View reference on PubMed
    • View reference on publisher's website
  387. Antonelli M, Conti G, Rocco M et al (1998) A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 339(7):429–435
    • View reference on PubMed
    • View reference on publisher's website
  388. Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A (2003) Noninvasive respiratory ventilation in severe hypoxemic failure: a randomized clinical trial. Am J Respir Crit Care Med 168(12):1438–1444
    • View reference on PubMed
    • View reference on publisher's website
  389. Frat JP, Thille AW, Mercat A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372(23):2185–2196
    • View reference on PubMed
    • View reference on publisher's website
  390. Klessig HT, Geiger HJ, Murray MJ, Coursin DB (1992) A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle-relaxants. Crit Care Med 20(9):1341–1345
    • View reference on PubMed
    • View reference on publisher's website
  391. Murray MJ, Cowen J, DeBlock H et al (2002) Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30(1):142–156
    • View reference on PubMed
    • View reference on publisher's website
  392. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN (1991) Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey. JAMA. 266(20):2870–2875
    • View reference on PubMed
  393. Freebairn RC, Derrick J, Gomersall CD, Young RJ, Joynt GM (1997) Oxygen delivery, oxygen consumption, and gastric intramucosal pH are not improved by a computer-controlled, closed-loop, vecuronium infusion in severe sepsis and septic shock. Crit Care Med 25(1):72–77
    • View reference on PubMed
    • View reference on publisher's website
  394. Papazian L, Forel JM, Gacouin A et al (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363(12):1107–1116
    • View reference on PubMed
    • View reference on publisher's website
  395. Alhazzani W, Alshahrani M, Jaeschke R et al (2013) Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care 17(2):R43
    • View reference on PubMed
    • View reference on publisher's website
  396. Forel JM, Roch A, Marin V et al (2006) Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 34(11):2749–2757
    • View reference on PubMed
    • View reference on publisher's website
  397. Shapiro BA, Warren J, Egol AB et al (1995) Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of Critical Care Medicine. Crit Care Med 23(9):1601–1605
    • View reference on PubMed
    • View reference on publisher's website
  398. Meyer KC, Prielipp RC, Grossman JE, Coursin DB (1994) Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 78(4):772–774
    • View reference on PubMed
    • View reference on publisher's website
  399. Lacomis D, Petrella JT, Giuliani MJ (1998) Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 21(5):610–617
    • View reference on PubMed
    • View reference on publisher's website
  400. Johnson KL, Cheung RB, Johnson SB, Roberts M, Niblett J, Manson D (1999) Therapeutic paralysis of critically ill trauma patients: perceptions of patients and their family members. Am J Crit Care 8(1):490–498
    • View reference on PubMed
  401. Ballard N, Robley L, Barrett D, Fraser D, Mendoza I (2006) Patients’ recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care 15(1):86–94 (quiz 5)
  402. Murray MJ, DeBlock H, Erstad B et al (2016) Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 44(11):2079–2103
    • View reference on PubMed
    • View reference on publisher's website
  403. Sibbald WJ, Short AK, Warshawski FJ, Cunningham DG, Cheung H (1985) Thermal dye measurements of extravascular lung water in critically ill patients. Intravascular Starling forces and extravascular lung water in the adult respiratory distress syndrome. Chest 87(5):585–592
    • View reference on PubMed
    • View reference on publisher's website
  404. Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD, Morris JA, Bernard GR (2002) Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 30(10):2175–2182
    • View reference on PubMed
    • View reference on publisher's website
  405. Mitchell JP, Schuller D, Calandrino FS, Schuster DP (1992) Improved outcome based on fluid management in critically ill patients requiring pulmonary-artery catheterization. Am Rev Respir Dis. 145(5):990–998
    • View reference on PubMed
    • View reference on publisher's website
  406. Schuller D (1991) Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? Chest 100(4):1068
    • View reference on PubMed
    • View reference on publisher's website
  407. Wiedemann HP, Wheeler AP, Bernard GR et al (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354(24):2564–2575
    • View reference on PubMed
    • View reference on publisher's website
  408. Perkins GD, McAuley DF, Thickett DR, Gao F (2006) The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 173(3):281–287
    • View reference on PubMed
    • View reference on publisher's website
  409. Gao Smith F, Perkins GD, Gates S et al (2012) Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 379(9812):229–235
    • View reference on PubMed
    • View reference on publisher's website
  410. Matthay MA, Brower RG, Carson S et al (2011) Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 184(5):561–568
    • View reference on PubMed
    • View reference on publisher's website
  411. Matthay MA, Brower RG, Carson S et al (2011) Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 184(5):561–568
    • View reference on PubMed
    • View reference on publisher's website
  412. Singh B, Tiwari AK, Singh K et al (2014) Beta2 agonist for the treatment of acute lung injury: a systematic review and meta-analysis. Respir Care. 59(2):288–296
    • View reference on PubMed
    • View reference on publisher's website
  413. Connors AF Jr, Speroff T, Dawson NV et al (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA. 276(11):889–897
    • View reference on PubMed
    • View reference on publisher's website
  414. Iberti TJ, Fischer EP, Leibowitz AB, Panacek EA, Silverstein JH, Albertson TE (1990) A multicenter study of physicians knowledge of the pulmonary artery catheter. JAMA 264(22):2928–2932
    • View reference on PubMed
    • View reference on publisher's website
  415. Osman D, Ridel C, Ray P et al (2007) Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med 35(1):64–68
    • View reference on PubMed
    • View reference on publisher's website
  416. Richard C, Warszawski J, Anguel N et al (2003) Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 290(20):2713–2720
    • View reference on PubMed
    • View reference on publisher's website
  417. Wheeler AP, Bernard GR, Thompson BT et al (2006) Pulmonary artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 354(21):2213–2224
    • View reference on PubMed
    • View reference on publisher's website
  418. Harvey S, Harrison DA, Singer M et al (2005) Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 366(9484):472–477
    • View reference on PubMed
    • View reference on publisher's website
  419. Rhodes A, Cusack RJ, Newman PJ, Grounds RM, Bennett ED (2002) A randomised, controlled trial of the pulmonary artery catheter in critically ill patients. Intensive Care Med 28(3):256–264
  420. Sandham JD, Hull RD, Brant RF et al (2003) A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 348(1):5–14
    • View reference on PubMed
    • View reference on publisher's website
  421. Shah MR, Hasselblad V, Stevenson LW et al (2005) Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA 294(13):1664–1670
    • View reference on PubMed
    • View reference on publisher's website
  422. Petrucci N, De Feo C (2013) Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev 2:CD003844
  423. Futier E, Constantin JM, Paugam-Burtz C et al (2013) A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med 369(5):428–437
    • View reference on PubMed
    • View reference on publisher's website
  424. Pinheiro de Oliveira R, Hetzel MP, dos Anjos Silva M, Dallegrave D, Friedman G (2010) Mechanical ventilation with high tidal volume induces inflammation in patients without lung disease. Crit Care 14(2):R39
  425. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer N (1999) Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 354(9193):1851–1858
    • View reference on PubMed
    • View reference on publisher's website
  426. Van Nieuwenhoven CA, Vandenbroucke-Grauls C, van Tiel FH et al (2006) Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Crit Care Med 34(2):396–402
    • View reference on PubMed
    • View reference on publisher's website
  427. Ouellette DR, Patel S, Girard TD et al (2016) Liberation from mechanical ventilation: an official American College of Chest Physicians/American Thoracic Society clinical practice guideline: inspiratory pressure augmentation during spontaneous breathing trials, protocols minimizing sedation, and non-invasive ventilation immediately after extubation. Chest 151(1):166–180. doi:10.1016/j.chest.2016.10.036
  428. Blackwood B, Burns KE, Cardwell CR, O’Halloran P (2014) Protocolized versus non-protocolized weaning for reducing the duration of mechanical ventilation in critically ill adult patients. Cochrane Database Syst Rev 11:CD006904
  429. Ely EW, Baker AM, Dunagan DP et al (1996) Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 335(25):1864–1869
    • View reference on PubMed
    • View reference on publisher's website
  430. Kress JP, Pohlman AS, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342(20):1471–1477
    • View reference on PubMed
    • View reference on publisher's website
  431. Girard TD, Kress JP, Fuchs BD et al (2008) Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 371(9607):126–134
    • View reference on PubMed
    • View reference on publisher's website
  432. Sevransky JE, Checkley W, Herrera P et al (2015) Protocols and hospital mortality in critically ill patients: the United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study. Crit Care Med 43(10):2076–2084
    • View reference on PubMed
    • View reference on publisher's website
  433. Schweickert WD, Pohlman MC, Pohlman AS et al (2009) Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 373(9678):1874–1882
    • View reference on PubMed
    • View reference on publisher's website
  434. Shehabi Y, Bellomo R, Reade MC et al (2012) Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med 186(8):724–731
    • View reference on PubMed
    • View reference on publisher's website
  435. Brook AD, Ahrens TS, Schaiff R et al (1999) Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27(12):2609–2615
    • View reference on PubMed
    • View reference on publisher's website
  436. Bucknall TK, Manias E, Presneill JJ (2008) A randomized trial of protocol-directed sedation management for mechanical ventilation in an Australian intensive care unit. Crit Care Med 36(5):1444–1450
    • View reference on PubMed
    • View reference on publisher's website
  437. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G (1998) The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest 114(2):541–548
    • View reference on PubMed
    • View reference on publisher's website
  438. Carson SS, Kress JP, Rodgers JE et al (2006) A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med 34(5):1326–1332
    • View reference on PubMed
    • View reference on publisher's website
  439. Mehta S, Burry L, Cook D et al (2012) Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA 308(19):1985–1992
    • View reference on PubMed
    • View reference on publisher's website
  440. Jansen JP, Naci H (2013) Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med 11:159
    • View reference on PubMed
    • View reference on publisher's website
  441. Strom T, Martinussen T, Toft P (2010) A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet 375(9713):475–480
    • View reference on PubMed
    • View reference on publisher's website
  442. Lonardo NW, Mone MC, Nirula R et al (2014) Propofol is associated with favorable outcomes compared with benzodiazepines in ventilated intensive care unit patients. Am J Respir Crit Care Med 189(11):1383–1394
    • View reference on PubMed
    • View reference on publisher's website
  443. Fraser GL, Devlin JW, Worby CP et al (2013) Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med 41(9 Suppl 1):S30–S38
    • View reference on PubMed
    • View reference on publisher's website
  444. Reade MC, Eastwood GM, Bellomo R et al (2016) Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial. JAMA 315(14):1460–1468
    • View reference on PubMed
    • View reference on publisher's website
  445. Barr J, Fraser GL, Puntillo K et al (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41(1):263–306
    • View reference on PubMed
    • View reference on publisher's website
  446. Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359–1367
    • View reference on PubMed
    • View reference on publisher's website
  447. Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354(5):449–461
    • View reference on PubMed
    • View reference on publisher's website
  448. Arabi YM, Dabbagh OC, Tamim HM et al (2008) Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 36(12):3190–3197
    • View reference on PubMed
    • View reference on publisher's website
  449. Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358(2):125–139
    • View reference on PubMed
    • View reference on publisher's website
  450. De La Rosa Gdel C, Donado JH, Restrepo AH et al (2008) Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 12(5):R120
    • View reference on publisher's website
  451. Finfer S, Blair D, Bellomo R et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360(13):1283–1297
    • View reference on PubMed
    • View reference on publisher's website
  452. Annane D, Cariou A, Maxime V et al (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303(4):341–348
    • View reference on PubMed
    • View reference on publisher's website
  453. Kalfon P, Giraudeau B, Ichai C et al (2014) Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial. Intensive Care Med 40(2):171–181
  454. Preiser JC, Devos P, Ruiz-Santana S et al (2009) A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 35(10):1738–1748
  455. Zhang RH, W; Li, T et al (2008) Evaluation of optimal goal of glucose control in critically ill patients. Chin J Clin Nutr 16:204–208
  456. Friedrich JO, Chant C, Adhikari NK (2010) Does intensive insulin therapy really reduce mortality in critically ill surgical patients? A reanalysis of meta-analytic data. Crit Care 14(5):324
    • View reference on PubMed
    • View reference on publisher's website
  457. Griesdale DE, de Souza RJ, van Dam RM et al (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180(8):821–827
    • View reference on PubMed
    • View reference on publisher's website
  458. Kansagara D, Fu R, Freeman M, Wolf F, Helfand M (2011) Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 154(4):268–282
    • View reference on PubMed
    • View reference on publisher's website
  459. Marik PE, Preiser JC (2010) Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest 137(3):544–551
    • View reference on PubMed
    • View reference on publisher's website
  460. Wiener RS, Wiener DC, Larson RJ (2008) Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 300(8):933–944
    • View reference on PubMed
    • View reference on publisher's website
  461. Ling Y, Li X, Gao X (2012) Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Intern Med. 23(6):564–574
    • View reference on PubMed
    • View reference on publisher's website
  462. Song F, Zhong LJ, Han L et al (2014) Intensive insulin therapy for septic patients: a meta-analysis of randomized controlled trials. Biomed Res Int. 2014:698265
    • View reference on PubMed
  463. American Diabetes Association (2014) Standards of medical care in diabetes—2014. Diabetes Care 37(Suppl 1):S14–S80
    • View reference on publisher's website
  464. Marvin MR, Inzucchi SE, Besterman BJ (2013) Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin. Diabetes Technol Ther. 15(3):246–252
    • View reference on PubMed
    • View reference on publisher's website
  465. Qaseem A, Chou R, Humphrey LL (2014) Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Inpatient glycemic control: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Am J Med Qual 29(2):95–98
    • View reference on PubMed
    • View reference on publisher's website
  466. Siegelaar SE, Hermanides J, Oudemans-van Straaten HM et al (2010) Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Crit Care 14(6):R224
    • View reference on PubMed
    • View reference on publisher's website
  467. Badawi O, Waite MD, Fuhrman SA, Zuckerman IH (2012) Association between intensive care unit-acquired dysglycemia and in-hospital mortality. Crit Care Med 40(12):3180–3188
    • View reference on PubMed
    • View reference on publisher's website
  468. Finfer S, Liu B, Chittock DR et al (2012) Hypoglycemia and risk of death in critically ill patients. N Engl J Med 367(12):1108–1118
    • View reference on PubMed
    • View reference on publisher's website
  469. Kalfon P, Le Manach Y, Ichai C et al (2015) Severe and multiple hypoglycemic episodes are associated with increased risk of death in ICU patients. Crit Care 19:153
    • View reference on PubMed
    • View reference on publisher's website
  470. Krinsley JS (2008) Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 36(11):3008–3013
    • View reference on PubMed
    • View reference on publisher's website
  471. Todi S, Bhattacharya M (2014) Glycemic variability and outcome in critically ill. Indian J Crit Care Med. 18(5):285–290
    • View reference on PubMed
    • View reference on publisher's website
  472. Kauffmann RM, Hayes RM, Jenkins JM et al (2011) Provision of balanced nutrition protects against hypoglycemia in the critically ill surgical patient. JPEN J Parenter Enteral Nutr 35(6):686–694
    • View reference on PubMed
    • View reference on publisher's website
  473. Egi M, Bellomo R, Stachowski E et al (2008) Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 36(8):2249–2255
    • View reference on PubMed
    • View reference on publisher's website
  474. Krinsley JS (2009) Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol. 3(6):1292–1301
    • View reference on PubMed
    • View reference on publisher's website
  475. Krinsley JS, Preiser JC (2015) Time in blood glucose range 70 to 140 mg/dl > 80% is strongly associated with increased survival in non-diabetic critically ill adults. Crit Care 19:179
    • View reference on PubMed
    • View reference on publisher's website
  476. Egi M, Bellomo R, Stachowski E et al (2011) The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 39(1):105–111
    • View reference on PubMed
    • View reference on publisher's website
  477. Sandler V, Misiasz MR, Jones J, Baldwin D (2014) Reducing the risk of hypoglycemia associated with intravenous insulin: experience with a computerized insulin infusion program in 4 adult intensive care units. J Diabetes Sci Technol. 8(5):923–929
    • View reference on PubMed
    • View reference on publisher's website
  478. Pereira AJ, Correa TD, de Almeida FP et al (2015) Inaccuracy of venous point-of-care glucose measurements in critically ill patients: a cross-sectional study. PLoS ONE 10(6):e0129568
    • View reference on PubMed
    • View reference on publisher's website
  479. Hoedemaekers CWE, Gunnewiek JMTK, Prinsen MA, Willems JL, Van der Hoeven JG (2008) Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med 36(11):3062–3066
    • View reference on PubMed
    • View reference on publisher's website
  480. Inoue S, Egi M, Kotani J, Morita K (2013) Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: systematic review. Crit Care 17(2):R48
    • View reference on PubMed
    • View reference on publisher's website
  481. Kanji S, Buffie J, Hutton B et al (2005) Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 33(12):2778–2785
    • View reference on PubMed
    • View reference on publisher's website
  482. Khan AI, Vasquez Y, Gray J, Wians FH Jr, Kroll MH (2006) The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med 130(10):1527–1532
    • View reference on PubMed
  483. Rice MJ, Coursin DB (2016) Glucose meters: here today, gone tomorrow? Crit Care Med 44(2):e97–e100
    • View reference on PubMed
    • View reference on publisher's website
  484. Klonoff DC, Draznin B, Drincic A et al (2015) PRIDE Statement on the need for a moratorium on the CMS plan to cite hospitals for performing point-of-care capillary blood glucose monitoring on critically ill patients. J Clin Endocrinol Metab 100(10):3607–3612
    • View reference on PubMed
    • View reference on publisher's website
  485. Wilson M, Weinreb J, Hoo GW (2007) Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 30(4):1005–1011
    • View reference on PubMed
    • View reference on publisher's website
  486. Dortch MJ, Mowery NT, Ozdas A et al (2008) A computerized insulin infusion titration protocol improves glucose control with less hypoglycemia compared to a manual titration protocol in a trauma intensive care unit. JPEN J Parenter Enteral Nutr 32(1):18–27
    • View reference on PubMed
    • View reference on publisher's website
  487. Newton CA, Smiley D, Bode BW et al (2010) A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms. J Hosp Med. 5(8):432–437
    • View reference on PubMed
    • View reference on publisher's website
  488. Bartlett RH, Mault JR, Dechert RE, Palmer J, Swartz RD, Port FK (1986) Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure. Surgery. 100(2):400–408
    • View reference on PubMed
  489. Bellomo R, Farmer M, Parkin G, Wright C, Boyce N (1995) Severe acute renal failure: a comparison of acute continuous hemodiafiltration and conventional dialytic therapy. Nephron. 71(1):59–64
    • View reference on PubMed
    • View reference on publisher's website
  490. Bellomo R, Mansfield D, Rumble S, Shapiro J, Parkin G, Boyce N (1992) Acute renal failure in critical illness. Conventional dialysis versus acute continuous hemodiafiltration. ASAIO J 38(3):M654–M657
    • View reference on PubMed
    • View reference on publisher's website
  491. Kierdorf H (1991) Continuous versus intermittent treatment: clinical results in acute renal failure. In: Sieberth HG, Mann H, Stummvoll HK (eds) Continuous hemofiltration. Karger, Basel, pp 1–12
  492. Mauritz W, Sporn P, Schindler I, Zadrobilek E, Roth E, Appel W (1986) Acute renal failure in abdominal infection. Comparison of hemodialysis and continuous arteriovenous hemofiltration. Anasth Intensivther Notfallmed. 21(4):212–217
    • View reference on PubMed
    • View reference on publisher's website
  493. Guerin C, Girard R, Selli JM, Ayzac L (2002) Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey. Intensive Care Med 28(10):1411–1418
  494. Van Bommel E, Bouvy ND, So KL et al (1995) Acute dialytic support for the critically iII: intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am J Nephrol 15(3):192–200
    • View reference on PubMed
    • View reference on publisher's website
  495. Kellum JA, Angus DC, Johnson JP et al (2002) Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28(1):29–37
  496. Tonelli M, Manns B, Feller-Kopman D (2002) Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40(5):875–885
    • View reference on PubMed
    • View reference on publisher's website
  497. Augustine JJ, Sandy D, Seifert TH, Paganini EP (2004) A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 44(6):1000–1007
    • View reference on PubMed
    • View reference on publisher's website
  498. Gasparovic V, Filipovic-Grcic I, Merkler M, Pisl Z (2003) Continuous renal replacement therapy (CRRT) or intermittent hemodialysis (IHD)—What is the procedure of choice in critically ill patients? Ren Fail 25(5):855–862
    • View reference on PubMed
    • View reference on publisher's website
  499. Mehta RL, McDonald B, Gabbai FB et al (2001) A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60(3):1154–1163
    • View reference on PubMed
    • View reference on publisher's website
  500. Uehlinger DE, Jakob SM, Ferrari P et al (2005) Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 20(8):1630–1637
    • View reference on PubMed
    • View reference on publisher's website
  501. Vinsonneau C, Camus C, Combes A et al (2006) Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 368(9533):379–385
    • View reference on PubMed
    • View reference on publisher's website
  502. John S, Griesbach D, Baumgartel M, Weihprecht H, Schmieder RE, Geiger H (2001) Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant 16(2):320–327
    • View reference on PubMed
    • View reference on publisher's website
  503. Misset B, Timsit JF, Chevret S, Renaud B, Tamion F, Carlet J (1996) A randomized cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure. Intensive Care Med 22(8):742–746
  504. Bouman CSC, Oudemans-van Straaten HM, Tijssen JGP, Zandstra DF, Kesecioglu J (2002) Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30(10):2205–2211
    • View reference on PubMed
    • View reference on publisher's website
  505. Ronco C, Bellomo R, Homel P et al (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356(9223):26–30
    • View reference on PubMed
    • View reference on publisher's website
  506. Bellomo R, Cass A, Cole L et al (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361(17):1627–1638
    • View reference on PubMed
    • View reference on publisher's website
  507. Palevsky PM, Zhang JH, O’Connor TZ et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359(1):7–20
    • View reference on PubMed
    • View reference on publisher's website
  508. Gaudry S, Hajage D, Schortgen F et al (2016) Initiation strategies for renal replacement therapy in the intensive care unit. N Engl J Med 375(2):122–133
    • View reference on PubMed
    • View reference on publisher's website
  509. Zarbock A, Kellum JA, Schmidt C et al (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315(20):2190–2199
    • View reference on PubMed
    • View reference on publisher's website
  510. Cooper DJ, Walley KR, Wiggs BR, Russell JA (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med 112(7):492–498
    • View reference on PubMed
    • View reference on publisher's website
  511. Mathieu D, Neviere R, Billard V, Fleyfel M, Wattel F (1991) Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 19(11):1352–1356
    • View reference on PubMed
    • View reference on publisher's website
  512. Cook D, Crowther M, Meade M et al (2005) Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33(7):1565–1571
    • View reference on PubMed
    • View reference on publisher's website
  513. Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e195S–e226S
    • View reference on PubMed
    • View reference on publisher's website
  514. Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41(9):2088–2098
    • View reference on PubMed
    • View reference on publisher's website
  515. Levi M, Levy M, Williams MD et al (2007) Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated). Am J Respir Crit Care Med 176(5):483–490
    • View reference on PubMed
    • View reference on publisher's website
  516. Beitland S, Sandven I, Kjaervik LK, Sandset PM, Sunde K, Eken T (2015) Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 41(7):1209–1219
  517. Phung OJ, Kahn SR, Cook DJ, Murad MH (2011) Dosing frequency of unfractionated heparin thromboprophylaxis: a meta-analysis. Chest 140(2):374–381
    • View reference on PubMed
    • View reference on publisher's website
  518. Mahan CE, Pini M, Spyropoulos AC (2010) Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing. Intern Emerg Med 5(4):299–306
    • View reference on PubMed
    • View reference on publisher's website
  519. Junqueira DR, Perini E, Penholati RR Carvalho MG (2012) Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev 9:CD007557
  520. Cook D, Meade M, Guyatt G et al (2011) Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 364(14):1305–1314
    • View reference on PubMed
    • View reference on publisher's website
  521. Fowler RA, Mittmann N, Geerts W et al (2014) Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA 312(20):2135–2145
    • View reference on PubMed
    • View reference on publisher's website
  522. Douketis J, Cook D, Meade M et al (2008) Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. Arch Intern Med 168(16):1805–1812
    • View reference on PubMed
    • View reference on publisher's website
  523. Arabi YM, Alsolamy S, Al-Dawood A et al (2016) Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial. Trials. 17:390
    • View reference on PubMed
    • View reference on publisher's website
  524. Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ (2008) Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 4:CD005258
  525. Falck-Ytter Y, Francis CW, Johanson NA et al (2012) Prevention of VTE in orthopedic surgery patients: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e278S–e325S
    • View reference on PubMed
    • View reference on publisher's website
  526. Gould MK, Garcia DA, Wren SM et al (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e227S–e277S
    • View reference on PubMed
    • View reference on publisher's website
  527. Pavon JM, Adam SS, Razouki ZA et al (2016) Effectiveness of intermittent pneumatic compression devices for venous thromboembolism prophylaxis in high-risk surgical patients: a systematic review. J Arthroplasty 31(2):524–532
    • View reference on PubMed
    • View reference on publisher's website
  528. Sachdeva A, Dalton M, Amaragiri SV, Lees T (2014) Graduated compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 12:CD001484
  529. Arabi YM, Khedr M, Dara SI et al (2013) Use of intermittent pneumatic compression and not graduated compression stockings is associated with lower incident VTE in critically ill patients: a multiple propensity scores adjusted analysis. Chest 144(1):152–159
    • View reference on PubMed
    • View reference on publisher's website
  530. Cook DJ, Griffith LE, Walter SD et al (2001) The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 5(6):368–375
    • View reference on PubMed
    • View reference on publisher's website
  531. Bardou M, Quenot JP, Barkun A (2015) Stress-related mucosal disease in the critically ill patient. Nat Rev Gastroenterol Hepatol. 12(2):98–107
    • View reference on PubMed
    • View reference on publisher's website
  532. Cook DJ, Fuller HD, Guyatt GH et al (1994) Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 330(6):377–381
    • View reference on PubMed
    • View reference on publisher's website
  533. Krag M, Perner A, Wetterslev J et al (2015) Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med 41(5):833–845
  534. Andersson B, Nilsson J, Brandt J, Hoglund P, Andersson R (2005) Gastrointestinal complications after cardiac surgery. Br J Surg 92(3):326–333
    • View reference on PubMed
    • View reference on publisher's website
  535. Bruno JJ, Canada TW, Wakefield CD, Nates JL (2009) Stress-related mucosal bleeding in critically ill oncology patients. J Oncol Pharm Pract. 15(1):9–16
    • View reference on PubMed
    • View reference on publisher's website
  536. D’Ancona G, Baillot R, Poirier B et al (2003) Determinants of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 30(4):280–285
    • View reference on PubMed
  537. Faisy C, Guerot E, Diehl JL, Iftimovici E, Fagon JY (2003) Clinically significant gastrointestinal bleeding in critically ill patients with and without stress ulcer prophylaxis. Intensive Care Med 29(8):1306–1313
  538. Krag M, Perner A, Wetterslev J, Wise MP, Hylander Moller M (2014) Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med 40(1):11–22
  539. Sasabuchi Y, Matsui H, Lefor AK, Fushimi K, Yasunaga H (2016) Risks and benefits of stress ulcer prophylaxis for patients with severe sepsis. Crit Care Med 44(7):e464–e469
    • View reference on PubMed
    • View reference on publisher's website
  540. Eastwood GM, Litton E, Bellomo R et al (2014) Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units. Crit Care Resusc 16(3):170–174
    • View reference on PubMed
  541. Krag M, Perner A, Wetterslev J et al (2015) Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiol Scand 59(5):576–585
    • View reference on PubMed
    • View reference on publisher's website
  542. Preslaski CR, Mueller SW, Kiser TH, Fish DN, MacLaren R (2014) A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit. J Clin Pharm Ther 39(6):658–662
    • View reference on PubMed
    • View reference on publisher's website
  543. Shears M, Alhazzani W, Marshall JC et al (2016) Stress ulcer prophylaxis in critical illness: a Canadian survey. Can J Anaesth 63(6):718–724
    • View reference on PubMed
    • View reference on publisher's website
  544. Alshamsi F, Belley-Cote E, Cook D et al (2016) Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 20(1):120
    • View reference on PubMed
    • View reference on publisher's website
  545. Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ (2013) Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 41(3):693–705
    • View reference on PubMed
    • View reference on publisher's website
  546. Barkun AN, Bardou M, Pham CQ, Martel M (2012) Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis. Am J Gastroenterol 107(4):507–520 (quiz 21)
  547. Barkun AN, Adam V, Martel M, Bardou M (2013) Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists. Value Health. 16(1):14–22
    • View reference on PubMed
    • View reference on publisher's website
  548. MacLaren R, Campbell J (2014) Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients. Crit Care Med 42(4):809–815
    • View reference on PubMed
    • View reference on publisher's website
  549. Villet S, Chiolero RL, Bollmann MD et al (2005) Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr. 24(4):502–509
    • View reference on PubMed
    • View reference on publisher's website
  550. Adams S, Dellinger EP, Wertz MJ, Oreskovich MR, Simonowitz D, Johansen K (1986) Enteral versus parenteral nutritional support following laparotomy for trauma: a randomized prospective trial. J Trauma 26(10):882–891
    • View reference on PubMed
    • View reference on publisher's website
  551. Borzotta AP, Pennings J, Papasadero B et al (1994) Enteral versus parenteral nutrition after severe closed head injury. J Trauma 37(3):459–468
    • View reference on PubMed
    • View reference on publisher's website
  552. Dunham CM, Frankenfield D, Belzberg H, Wiles C, Cushing B, Grant Z (1994) Gut failure—predictor of or contributor to mortality in mechanically ventilated blunt trauma patients? J Trauma 37(1):30–34
    • View reference on PubMed
    • View reference on publisher's website
  553. Harvey SE, Parrott F, Harrison DA et al (2014) Trial of the route of early nutritional support in critically ill adults. N Engl J Med 371(18):1673–1684
    • View reference on PubMed
    • View reference on publisher's website
  554. Justo Meirelles CM, de Aguilar-Nascimento JE (2011) Enteral or parenteral nutrition in traumatic brain injury: a prospective randomised trial. Nutr Hosp 26(5):1120–1124
    • View reference on PubMed
  555. Kalfarentzos F, Kehagias J, Mead N, Kokkinis K, Gogos CA (1997) Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 84(12):1665–1669
    • View reference on PubMed
    • View reference on publisher's website
  556. Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM (1989) TEN versus TPN following major abdominal trauma—reduced septic morbidity. J Trauma 29(7):916–922 (discussion 22–23)
  557. Peterson VM, Moore EE, Jones TN et al (1988) Total enteral nutrition versus total parenteral nutrition after major torso injury: attenuation of hepatic protein reprioritization. Surgery. 104(2):199–207
    • View reference on PubMed
  558. Sun JK, Mu XW, Li WQ, Tong ZH, Li J, Zheng SY (2013) Effects of early enteral nutrition on immune function of severe acute pancreatitis patients. World J Gastroenterol 19(6):917–922
    • View reference on PubMed
    • View reference on publisher's website
  559. Wang G, Wen J, Xu L et al (2013) Effect of enteral nutrition and ecoimmunonutrition on bacterial translocation and cytokine production in patients with severe acute pancreatitis. J Surg Res 183(2):592–597
    • View reference on PubMed
    • View reference on publisher's website
  560. Harvey SE, Parrott F, Harrison DA et al (2016) A multicentre, randomised controlled trial comparing the clinical effectiveness and cost-effectiveness of early nutritional support via the parenteral versus the enteral route in critically ill patients (CALORIES). Health Technol Assess 20(28):1–144
    • View reference on publisher's website
  561. Kudsk KA (2002) Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 183(4):390–398
    • View reference on PubMed
    • View reference on publisher's website
  562. McClave SA, Heyland DK (2009) The physiologic response and associated clinical benefits from provision of early enteral nutrition. Nutr Clin Pract. 24(3):305–315
    • View reference on PubMed
    • View reference on publisher's website
  563. Casaer MP, Mesotten D, Hermans G et al (2011) Early versus late parenteral nutrition in critically ill adults. N Engl J Med 365(6):506–517
    • View reference on PubMed
    • View reference on publisher's website
  564. Doig GS, Simpson F, Sweetman EA et al (2013) Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial. JAMA 309(20):2130–2138
    • View reference on PubMed
    • View reference on publisher's website
  565. Rapp RP, Donaldson ES, Bivins BA (1983) Parenteral nutrition in a patient with familial type IV hypertriglyceridemia: a dilemma. Drug Intell Clin Pharm. 17(6):458–460
    • View reference on PubMed
  566. Young B, Ott L, Haack D et al (1987) Effect of total parenteral nutrition upon intracranial pressure in severe head injury. J Neurosurg 67(1):76–80
    • View reference on PubMed
    • View reference on publisher's website
  567. Sadique Z, Grieve R, Harrison D, Rowan K (2015) Cost-effectiveness of early parenteral versus enteral nutrition in critically ill patients. Value Health. 18(7):A532
    • View reference on PubMed
    • View reference on publisher's website
  568. Chiarelli A, Enzi G, Casadei A, Baggio B, Valerio A, Mazzoleni F (1990) Very early nutrition supplementation in burned patients. Am J Clin Nutr 51(6):1035–1039
    • View reference on PubMed
  569. Dvorak MF, Noonan VK, Bélanger et al (2004) Early versus late enteral feeding in patients with acute cervical spinal cord injury: a pilot study. Spine (Phila Pa 1976) 29(9):E175–E180
  570. Eyer SD, Micon LT, Konstantinides FN et al (1993) Early enteral feeding does not attenuate metabolic response after blunt trauma. J Trauma 34(5):639–644
    • View reference on PubMed
    • View reference on publisher's website
  571. Grahm TW, Zadrozny DB, Harrington T (1989) The benefits of early jejunal hyperalimentation in the head-injured patient. Neurosurgery. 25(5):729–735
    • View reference on PubMed
    • View reference on publisher's website
  572. Hasse JM, Blue LS, Liepa GU et al (1995) Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr 19(6):437–443
    • View reference on PubMed
    • View reference on publisher's website
  573. Minard G, Kudsk KA, Melton S, Patton JH, Tolley EA (2000) Early versus delayed feeding with an immune-enhancing diet in patients with severe head injuries. JPEN J Parenter Enteral Nutr 24(3):145–149
    • View reference on PubMed
    • View reference on publisher's website
  574. Moore EE, Jones TN (1986) Benefits of immediate jejunostomy feeding after major abdominal-trauma—a prospective, randomized study. J Trauma 26(10):874–881
    • View reference on PubMed
    • View reference on publisher's website
  575. Nguyen NQ, Fraser RJ, Bryant LK et al (2008) The impact of delaying enteral feeding on gastric emptying, plasma cholecystokinin, and peptide YY concentrations in critically ill patients. Crit Care Med 36(5):1469–1474
    • View reference on PubMed
    • View reference on publisher's website
  576. Peng YZ, Yuan ZQ, Xiao GX (2001) Effects of early enteral feeding on the prevention of enterogenic infection in severely burned patients. Burns. 27(2):145–149
    • View reference on PubMed
    • View reference on publisher's website
  577. Singh G, Ram RP, Khanna SK (1998) Early postoperative enteral feeding in patients with nontraumatic intestinal perforation and peritonitis. J Am Coll Surg 187(2):142–146
    • View reference on PubMed
    • View reference on publisher's website
  578. Chuntrasakul C, Chinswangwatanakul V, Chockvivatanavanit S, Siltharm S, Pongprasobchai T, Bunnak A (1996) Early nutritional support in severe traumatic patients. J Med Assoc Thai 79(1):21–26
    • View reference on PubMed
  579. Chourdakis M, Kraus MM, Tzellos T et al (2012) Effect of early compared with delayed enteral nutrition on endocrine function in patients with traumatic brain injury: an open-labeled randomized trial. JPEN J Parenter Enteral Nutr 36(1):108–116
    • View reference on PubMed
    • View reference on publisher's website
  580. Doig GS, Heighes PT, Simpson F, Sweetman EA (2011) Early enteral nutrition reduces mortality in trauma patients requiring intensive care: a meta-analysis of randomised controlled trials. Injury. 42(1):50–56
    • View reference on PubMed
    • View reference on publisher's website
  581. Doig GS, Heighes PT, Simpson F, Sweetman EA, Davies AR (2009) Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med 35(12):2018–2027
  582. Malhotra A, Mathur AK, Gupta S (2004) Early enteral nutrition after surgical treatment of gut perforations: a prospective randomised study. J Postgrad Med 50(2):102–106
    • View reference on PubMed
  583. Pupelis G, Austrums E, Jansone A, Sprucs R, Wehbi H (2000) Randomised trial of safety and efficacy of postoperative enteral feeding in patients with severe pancreatitis: preliminary report. Eur J Surg 166(5):383–387
    • View reference on PubMed
    • View reference on publisher's website
  584. Arabi YM, Aldawood AS, Haddad SH et al (2015) Permissive underfeeding or standard enteral feeding in critically ill adults. N Engl J Med 372(25):2398–2408
    • View reference on PubMed
    • View reference on publisher's website
  585. Marik PE, Hooper MH (2016) Normocaloric versus hypocaloric feeding on the outcomes of ICU patients: a systematic review and meta-analysis. Intensive Care Med 42(3):316–323
  586. Arabi YM, Tamim HM, Dhar GS et al (2011) Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial. Am J Clin Nutr 93(3):569–577
    • View reference on PubMed
    • View reference on publisher's website
  587. Charles EJ, Petroze RT, Metzger R et al (2014) Hypocaloric compared with eucaloric nutritional support and its effect on infection rates in a surgical intensive care unit: a randomized controlled trial. Am J Clin Nutr 100(5):1337–1343
    • View reference on PubMed
    • View reference on publisher's website
  588. Ibrahim EH, Mehringer L, Prentice D et al (2002) Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 26(3):174–181
    • View reference on PubMed
    • View reference on publisher's website
  589. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Rice TW, Wheeler AP et al (2012) Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA 307(8):795–803
  590. Petros S, Horbach M, Seidel F, Weidhase L (2016) Hypocaloric vs normocaloric nutrition in critically ill patients: a prospective randomized pilot trial. JPEN J Parenter Enteral Nutr 40(2):242–249
    • View reference on PubMed
    • View reference on publisher's website
  591. Rice TW, Mogan S, Hays MA, Bernard GR, Jensen GL, Wheeler AP (2011) Randomized trial of initial trophic versus full-energy enteral nutrition in mechanically ventilated patients with acute respiratory failure. Crit Care Med 39(5):967–974
    • View reference on PubMed
    • View reference on publisher's website
  592. Needham DM, Dinglas VD, Bienvenu OJ et al (2013) One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trial. BMJ 346:f1532
    • View reference on PubMed
    • View reference on publisher's website
  593. Garcia de Acilu M, Leal S, Caralt B, Roca O, Sabater J, Masclans JR (2015) The role of omega-3 polyunsaturated fatty acids in the treatment of patients with acute respiratory distress syndrome: a clinical review. Biomed Res Int 2015:653750
  594. Manzanares W, Dhaliwal R, Jurewitsch B, Stapleton RD, Jeejeebhoy KN, Heyland DK (2014) Parenteral fish oil lipid emulsions in the critically ill: a systematic review and meta-analysis. JPEN J Parenter Enteral Nutr 38(1):20–28
    • View reference on PubMed
    • View reference on publisher's website
  595. Zhu D, Zhang Y, Li S, Gan L, Feng H, Nie W (2014) Enteral omega-3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Intensive Care Med 40(4):504–512
  596. Rice TW, Wheeler AP, Thompson BT, deBoisblanc BP, Steingrub J, Rock P (2011) Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA 306(14):1574–1581
    • View reference on PubMed
    • View reference on publisher's website
  597. McClave SA, DeMeo MT, DeLegge MH et al (2002) North American Summit on Aspiration in the Critically Ill Patient: consensus statement. JPEN J Parenter Enteral Nutr 26(6 Suppl):S80–S85
    • View reference on PubMed
    • View reference on publisher's website
  598. McClave SA, Lukan JK, Stefater JA et al (2005) Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients. Crit Care Med 33(2):324–330
    • View reference on PubMed
    • View reference on publisher's website
  599. Metheny NA, Schallom L, Oliver DA, Clouse RE (2008) Gastric residual volume and aspiration in critically ill patients receiving gastric feedings. Am J Crit Care 17(6):512–519 (quiz 20)
  600. Montejo JC, Minambres E, Bordeje L et al (2010) Gastric residual volume during enteral nutrition in ICU patients: the REGANE study. Intensive Care Med 36(8):1386–1393
  601. Poulard F, Dimet J, Martin-Lefevre L et al (2010) Impact of not measuring residual gastric volume in mechanically ventilated patients receiving early enteral feeding: a prospective before-after study. JPEN J Parenter Enteral Nutr 34(2):125–130
    • View reference on PubMed
    • View reference on publisher's website
  602. Reignier J, Mercier E, Le Gouge A et al (2013) Effect of not monitoring residual gastric volume on risk of ventilator-associated pneumonia in adults receiving mechanical ventilation and early enteral feeding: a randomized controlled trial. JAMA 309(3):249–256
    • View reference on PubMed
    • View reference on publisher's website
  603. Elke G, Felbinger TW, Heyland DK (2015) Gastric residual volume in critically ill patients: a dead marker or still alive? Nutr Clin Pract. 30(1):59–71
    • View reference on PubMed
    • View reference on publisher's website
  604. Van Noord C, Dieleman JP, van Herpen G, Verhamme K, Sturkenboom MC (2010) Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands. Drug Saf 33(11):1003–1014
    • View reference on PubMed
    • View reference on publisher's website
  605. Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM (2004) Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 351(11):1089–1096
    • View reference on PubMed
    • View reference on publisher's website
  606. Lewis K, Alqahtani Z, McIntyre L et al (2016) The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials. Crit Care 20(1):259
    • View reference on PubMed
    • View reference on publisher's website
  607. Freeman BD, Dixon DJ, Coopersmith CM, Zehnbauer BA, Buchman TG (2008) Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients. Pharmacoepidemiol Drug Saf 17(10):971–981
    • View reference on PubMed
    • View reference on publisher's website
  608. Fruhwald S, Kainz J (2010) Effect of ICU interventions on gastrointestinal motility. Curr Opin Crit Care. 16(2):159–164
    • View reference on PubMed
    • View reference on publisher's website
  609. Mentec H, Dupont H, Bocchetti M, Cani P, Ponche F, Bleichner G (2001) Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med 29(10):1955–1961
    • View reference on PubMed
    • View reference on publisher's website
  610. Dive A, Foret F, Jamart J, Bulpa P, Installe E (2000) Effect of dopamine on gastrointestinal motility during critical illness. Intensive Care Med 26(7):901–907
  611. Dive A, Miesse C, Jamart J, Evrard P, Gonzalez M, Installe E (1994) Duodenal motor response to continuous enteral feeding is impaired in mechanically ventilated critically ill patients. Clin Nutr. 13(5):302–306
    • View reference on publisher's website
    • View reference on PubMed
  612. Zaloga GP, Marik P (2000) Promotility agents in the intensive care unit. Crit Care Med 28(7):2657–2659
    • View reference on PubMed
    • View reference on publisher's website
  613. Tiancha H, Jiyong J, Min Y (2015) How to promote bedside placement of the postpyloric feeding tube: a network meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 39(5):521–530
    • View reference on PubMed
    • View reference on publisher's website
  614. Alhazzani W, Almasoud A, Jaeschke R et al (2013) Small bowel feeding and risk of pneumonia in adult critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 17(4):R127
    • View reference on PubMed
    • View reference on publisher's website
  615. Deane AM, Dhaliwal R, Day AG, Ridley EJ, Davies AR, Heyland DK (2013) Comparisons between intragastric and small intestinal delivery of enteral nutrition in the critically ill: a systematic review and meta-analysis. Crit Care 17(3):R125
    • View reference on PubMed
    • View reference on publisher's website
  616. Alhazzani W, Jacobi J, Sindi A et al (2013) The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 41(6):1555–1564
    • View reference on PubMed
    • View reference on publisher's website
  617. Valenta J, Brodska H, Drabek T, Hendl J, Kazda A (2011) High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med 37(5):808–815
  618. Bloos F, Trips E, Nierhaus A et al (2016) Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA Int Med. 176(9):1266–1276
    • View reference on publisher's website
  619. Bertolini G, Iapichino G, Radrizzani D et al (2003) Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 29(5):834–840
  620. Suchner U, Kuhn KS, Furst P (2000) The scientific basis of immunonutrition. Proc Nutr Soc. 59(4):553–563
    • View reference on PubMed
    • View reference on publisher's website
  621. Bower RH, Cerra FB, Bershadsky B et al (1995) Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 23(3):436–449
    • View reference on PubMed
    • View reference on publisher's website
  622. Caparros T, Lopez J, Grau T (2001) Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet. The effect on nosocomial infections and outcome. JPEN J Parenter Enteral Nutr 25(6):299–309
    • View reference on PubMed
    • View reference on publisher's website
  623. Galban C, Montejo JC, Mesejo A et al (2000) An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 28(3):643–648
    • View reference on PubMed
    • View reference on publisher's website
  624. Santora R, Kozar RA (2010) Molecular mechanisms of pharmaconutrients. J Surg Res 161(2):288–294
    • View reference on PubMed
    • View reference on publisher's website
  625. Kieft H, Roos AN, van Drunen JDE, Bindels A, Bindels JG, Hofman Z (2005) Clinical outcome of immunonutrition in a heterogeneous intensive care population. Intensive Care Med 31(4):524–532
  626. Marik PE, Zaloga GP (2001) Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med 29(12):2264–2270
    • View reference on PubMed
    • View reference on publisher's website
  627. Avenell A (2006) Glutamine in critical care: current evidence from systematic reviews. Proc Nutr Soc. 65(3):236–241
    • View reference on PubMed
    • View reference on publisher's website
  628. Avenell A (2009) Hot topics in parenteral nutrition. Current evidence and ongoing trials on the use of glutamine in critically-ill patients and patients undergoing surgery. Proc Nutr Soc. 68(3):261–268
    • View reference on PubMed
    • View reference on publisher's website
  629. Jiang H, Chen W, Hu W, Cai B, Liao RJ (2009) The impact of glutamine-enhanced enteral nutrition on clinical outcome of patients with critical illness: a systematic review of randomized controlled trials. Zhonghua Shao Shang Za Zhi. 25(5):325–330
    • View reference on PubMed
  630. Novak F, Heyland DK, Avenell A, Drover JW, Su XY (2002) Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 30(9):2022–2029
    • View reference on PubMed
    • View reference on publisher's website
  631. Grau T, Bonet A, Minambres E et al (2011) The effect of L-alanyl-l-glutamine dipeptide supplemented total parenteral nutrition on inf